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1. Introduction 
 
Parvoviruses (PV) are small, non-enveloped DNA viruses that infect vertebrates and insects. They 
enter via endosomes and require low pH for penetration and productive infection (Basak.S and 
Tuner.H, 1992, Parker.JS and Parrish.CR, 2000). Following entry into the cell, the majority of the 
viruses appear to be retained in a perinuclear location (Bartlett.JS, et al, 2000 and Vihinen-
Ranta.M, et al, 2000), possibly in perinuclear recycling endosomes. 
 
Parvoviruses are classified into three genera, Parvoviruses (autonomous parvoviruses), 
Erythrovirus (human parvovirus, B19), and Dependovirus (adeno-associated virus, AAV). 
Autonomous parvoviruses infect a wide varity of mammalian and avian hosts (minute virus of 
mice, canine parvovirus, Feline parvovirus, Aleutian mink disease virus and Parvovirus H-1). 
Parvoviruses are lytic viruses, i.e necessary for leaving the cells. This lytic activity has been 
ascribed, at least in part, to the non-structural (NS) viral proteins (Caillet-Fauquet.P, et al, 1990 and 
Rayet.B, et al, 1998). 
 
Parvovirus H-1 and Kilham rat virus (KRV) were first identified in the late 1950s and belong to the 
rodent family which infects hamster/rat. Infection with rat H-1 virus can be lethal in fetal or 
perinatal animals, probably due to high numbers of mitotically active cells that serve as targets for 
cytolytic viral replication (Ball-Goodrich.LJ, et al, 2002). Entry of viruses into host cells starts by 
binding to the cell surface receptors, followed by penetration across the cellular membrane. 
Although cell entry of enveloped viruses is well characterized, but the mechanisms of viral entry 
and nuclear targeting of non-enveloped viruses are still poorly understood.  
 
Parvoviruses exhibit an icosahedral structure formed by the two capsid proteins VP1 and VP2. 
80% of the capsid proteins consists of VP2 and 20% of the larger VP1. VP1 comprises the entire 
amino acids sequence of VP2 and plus an additional terminal domain of 150-230 amino acids. Due 
to the mode of genome replication a viral protein termed NS1 is covalently linked to the viral DNA 
genome (Cotmore.SF, et al, 1998). NS1 is exposed to the surface of the virus (Cotmore.SF, et al, 
1989) but consistent with its function in replication – only in DNA containing capsids and not in 
empty ones. Parvoviruses (PVs) replicate with in the cell nuclei using the eukaryotic DNA 
polymerases α or δ. PVs require cell division for replication but they enter the nucleus independent 
upon the disintegration of the nuclear envelope (NE) that occurs upon mitosis. As numerous other 
viruses, (e.g. influenza and adeno viruses (Whittaker.GR, et al, 2000) all parvoviruses being 
investigated infect the cells by endocytosis requiring acidification (Bartlett.JS, et al, 2000, Basak.S, 
et al, 1992 and Parker.JS, 2000). The decreasing pH causes structural changes as the cleavage of 
some VP2 proteins by cellular proteases. Furthermore the initially hidden N terminal domain of 
VP1 (VP1 unique part, VP1up) becomes exposed (Suikkanen.S, et al, 2003). This region exhibits a 
phospholipase A2 (PLA2) domain that catalyzes the hydrolysis of phospholipids at the 2-acyl ester 
position (Zadori.Z, et al, 2001). It was shown that PLA2 is involved in the release of the capsid 
from the endosomal compartment into the cytosol (Suikkanen.S, et al, 2003, Zadori.Z, et al, 2003, 
Farr.GA and Zhang.LG, et al, 2005). This process is apparently inefficient as the vast majority of 
capsids end in the lysosomal compartment (Mani.B, et al, 2002) explaining the low ratio of virions 
to infectious units (~1:1000). 
 
Escaping the endosome parvoviruses use the microtubule network for the centripetal transport  
(Suikkanen.S, et al, 2003 and Vihinen-Ranta.M, et al, 1998). The following step of nuclear import 
is a controversial topic. VP1up contains clusters of basic amino acids similar to “classical” nuclear 
localization signals (NLS). One of these clusters showed a nuclear import capacity when being 
fused to BSA (Vihinen-Ranta.M, et al, 1997). Consequently it was assumed that the entire capsid 
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pass the nuclear pore complex (NPC) as described for the capsid of the hepatitis B virus (Kann.M, 
et al, 1999, Rabe.B, et al, 2003). Being of small diameter, the parvovirus falls below the 39 nm 
transport limit of the pore (Pante.N and Kann.M, 2002). 
 
However, others propose that the basic amino acids only form an NLS when being arranged in a 
trimeric form of one VP1 and two VP2 (Riolobos.L, et al, 2006) being dependent upon 
phosphorylation (Riolobos.L and Reguera.J 2006). This trimer however, is not result of 
acidification during parvovirus entry but is an assembly intermediate during synthesis of progeny 
virions. It was thus assumed that the exposure of this NLS contributes to the transport of the 
progeny capsid subunits into the nucleus where viral assembly occurs. Consistent with idea that 
another protein facilitates nuclear import of the viral genome are findings of Mani.B et al, who 
observed that genome and capsid proteins already dissociates in the endosomal / lysosomal 
compartment (Mani.B, et al, 2006). Following this scenario and considering that nucleic acids per 
se are not karyophilic, the genome attached NS1 should mediate the import. A corresponding NLS 
was identified on NS1 (Nuesch.JP, et al, 1993). Seemingly contradictory is a report that describes 
the removal of NS1 from the viral genome upon endocytosis (Cotmore.SF, et al, 1989) but it 
remains open whether this observation is related to capsids that are successfully infecting the cell 
or to those capsids ending in the lysosomal compartment. 
 
A third pathway was described by Zadori et al, who assumed that the PLA2 activity enables the 
parvoviral capsid to pass the nuclear envelope without using the NPC (Zadori.Z, et al, 2001). 
Seemingly consistent with this idea, MVM damages the NE after microinjection into the cytosol of 
Xenopus laevis oocytes (Cohen.S, et al, 2005). However, it must be considered, as these capsids 
have not undergone the pH induced structural change, they not exhibit the PLA2 domain strongly 
suggesting a yet unknown mechanism of parvoviral nuclear entry. Infact this assumption is in 
agreement with the observation that the parvoviral PLA2 induces only small pores into membranes 
allowing the diffusion of molecules of 3 kDa but retaining molecules of 10 kDa (Suikkanen.S, 
2003). 
 
The review literature of this thesis will briefly describe the features of cellular elements and their 
role in viral entry into the nucleus of the cell, as well as the processes of the viruses. The aim of my 
project is to investigate the mechanisms of the parvovirus H-1 entry since parvoviruses along with 
adenoviruses widely used as a major tool for gene therapy applications. 
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2. Review of the literature 
 
2.1 Overview:- How  viruses enter into animal cells 
 
Replication of virus occurs within living cells and uses the cellular machinery for the synthesis of 
their genome and other components. To gain access, they have evolved a variety of mechanisms to 
deliver their genes and accessory proteins into the host cells. In brief, virions must attach to the 
cell surface, penetrate the cell, and become sufficiently uncoated to make its genome accessible to 
viral or host machinery for transcription or translation. 
 
2.1.1 Attachment 
 
Attachment constitutes the specific binding of a viral protein (the ligand) to a component of the 
cell surface (the receptor). The viral cellular receptors are mainly glycoproteins. Binding site of 
the viral receptor varies depending on the virus. Enveloped viruses bind to cell surface receptors 
by their envelope glycoproteins (Grewe.C, et al, 1990) while non-enveloped viruses have been 
described to use grooves, depressions, loops or spikes of the virion surface as their receptor 
binding sites (Marsh.M and Helenius.A, 1989). In addition to the direct binding of virus to the 
plasma membrane, viruses might bind to the cell surface through soluble proteins intermediates 
such as antibodies or β2-microglobulin (Marsh.M and Helenius.A, 1989). Attachment of the 
viruses to the cells in many instances leads to irreversible changes in the surface of the virion. 
However, when penetration does not take place, the virus can detach and adsorb to a different cell 
as shown by orthomyxoviruses and paramyxoviruses, which carry a neuraminidase (receptor 
destroying enzyme) on their surface. Elution of these viruses from their receptors takes place by 
cleaving the terminal neuraminic acid from the polysaccharide chains of the receptors (Mahon.PJ, 
et al, 1995). 
 
2.1.2 Penetration 
 
Viral penetration is an energy-dependent process. Some of the viruses surf on the surface until 
they reach to the confined zone after that attachment occurs and involves one of the three 
mechanisms: (a) translocation of the entire virus across the plasma membrane, (b) endocytosis of 
the virus particle resulting in accumulation of the virus particles inside cytoplasmic vesicles, and 
(c) fusion of the viron envelope with the cellular membrane. Non-enveloped viruses penetrate by 
the first two mechanisms.  
 
Many viruses require exposure to an acidic pH during infectious entry (Marsh.M, et al, 1993). For 
example, influenza virus and semliki forest virus are well known example of enveloped viruses. 
They require the low pH (< 6) in the endosome to cause their glycoprotein spike complexes to 
undergo conformational changes needed for fusion of the viral envelope with endosomal 
membranes (Bullough.PA, et al, 1994, Kielian.M and Helenius.A, 1985). In the presence of drugs 
disrupting endosomal acidification processes, the infection caused by these viruses is blocked 
(Matlin.KS, et al, 1981, Kielian.M, 1995). Many non-enveloped viruses are also affected by these 
drugs. For example adenoviruses, rhinoviruses, reoviruses and parvoviruses require a low pH step 
for their productive infection. Infection by some pH-dependent viruses may be inhibited by 
indirect effects of these drug treatments on endosomal protease activation or on endosomal 
trafficking of viral particles (Clague.MJ, et al, 1994, Authier.FB, et al, 1996). Generally, viruses 
that require exposure to low pH for penetration enter their host cells by clathrin-mediated 
endocytosis to ensure the delivery to acidic organelles (Marsh.M and Pelchen- Matthews.A, 
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2000). Most viruses using endocytosis are adapted to escape from the early endosomes or the late 
endosomes to avoid the delivery to lysosomes, which would cause inactivation and degradation 
(Marsh.M and Helenius.A, 1989). 
 
2.1.3 Viral uncoating 
 
Penetrating into the cytoplasm in not merely enough for replication of many viral species, because 
most DNA viruses (except poxviruses), as well as some RNA species (influenza virus) replicate in 
the nucleus. The nucleus provides cellular factors needed for the amplification and transcription of 
their genomes as well as for the post transcriptional processing of viral mRNA. Therefore, these 
viruses have to transverse through the cytoplasm and enter the nucleus after penetrating the 
cellular membranes (Cullen.BR, 2001). Trafficking of cytoplasm depends on cytosolic filaments 
such as microtubules, actin filaments (Sodeik.B, 2000). The functional participation of the 
microtubules in cytoplasmic traffic has been reported for a number of viruses, and dynein-
mediated transport has been described for adenoviruses (Leopold.PL, et al, 2000).  
 
2.1.4 Entry 
 
After reaching to the nucleus, viruses can wait until the cell undergoes mitosis, when the nuclear 
envelope is temporarily lost, allowing the viral genome to become part of newly assembled 
nucleus. Viruses using this strategy (many retroviruses) are able to replicate only in dividing cells. 
More commonly, the genome of incoming viruses is transported to the nucleus, through the 
nuclear envelope of the interphase nucleus allowing replication also in non-dividing cells 
(Whittaker.GR, et al, 2000). Nuclear pore complex (NPC) plays a critical and vital role in viral 
nuclear import processes. Active nuclear import is mediated by different nuclear transport 
receptors (importins or karyopherins). Only few viruses are small enough to pass through the 
NPCs with their capsid shells. Viruses have different strategies to circumvent this size limitation. 
Many of the viruses undergo partial or full disassembly before nuclear entry such as adenoviruses.   
 
2.1.5 Assembly, maturation and release of progeny virus 
 
Viruses choose different fundamental strategies for their assembly, maturation and to release the 
progeny capsids. In case of picornaviruses, reovirus, adenoviruses and parvoviruses, involves 
intracellular assembly and maturation. Adeno-and parvoviruses assemble in the nucleus. The 
releasing mechanism of progeny virus from the infected cell depends on the structure of the virus. 
It has been accepted in the parvoviruses that non-enveloped viruses are released by the lysis of the 
cells. However, there are few evidence exists for the release of  some non-enveloped viruses 
without cell lysis, and one report indicates, polarised release of SV40 from the epithelial cells. In 
addition, few other examples like poliovirus, where cellular mechanisms used by viruses for the 
active release of non-enveloped viruses that are not the result of lysis of the host cell. Once the 
progeny viruses released, they can initiate infection in new cells, and a whole new round of virus 
replication and interaction with a host cell can begin. 
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2.2 Overview:- Parvovirus H-1 
 
2.2.1 Parvovirus infection and diseases 
 
Parvoviruses are wide spread throughout humans and animals including dogs and mice. Based on 
their lytic activity that facilitates progeny virus release they evoke a variety of different disease. 
The canine parvovirus (CPV) for instance causes enteric and mycardial diseases in dogs, the 
minute virus of mice (MVM) targets small intestine, lymphoid tissue, kidneys and cerebellum 
with sometimes devastating consequences as fetal death. There are two parvoviruses known to 
infect humans: B19 and the adeno-associated virus (AAV). While AAV is not related to any 
disease (Srivastava.A, 1994, Rabinowitz.JE, 2000), B19 causes a variety of different ailments. 
   The seroprevalence of B19 infections is 40 to 60% and most infections occur during childhood. At 
this stage of infection the most common illness is the erythema nodosum with rashes. Adults 
develop additional symptoms as joint pain or swelling, which may last several months. Due to the 
tropism of B19 for erythroid progenitor cells, fatal consequences occur when parvovirus B19 
infection will happen to pregnant women. In 10% the unborn baby will develop severe anaemia 
resulting in a miscarriage. Haemolytical crises have been observed in patients with different forms 
of anaemia and in immune compromised patients, as HIV infected individuals. Here, B19 is an 
opportunistic pathogen causing not only severe anaemia but focal encephalitis (Gyllensten.K, et 
al, 1994). Today there is no vaccine or medicine that prevents parvovirus B19 infection. 
 
2.2.2 Taxonomy 
 
Viruses of parvoviridae family are divided in to two subfamilies 1. Parvovirinae, which infect 
vertebrates. 2. Densovirinae, infect insects. Both subfamilies are further divided into three genera 
(Berns.KI and Giraud.C, 1996). Parvovirinae have three genera Parvovirus, Erythrovirus, and 
Dependovirus. In case of AAVs (Adeno-associated virus) need helper virus (adenovirus, herpes 
virus) co-infection for their replication (Janik.JE, et al, 1981). In the absence of helper virus AAV 
virion is able to infect the host cell efficiently but the genome undergoes an incomplete replication 
and integrates into the host genome to establish latency (Kotin.RM, et al, 1990, Samulski.RJ, et al, 
1991). Viruses of the genera Parvovirus and Erythrovirus are autonomous viruses replicating 
without helper virus infection. However, members of both genera needs functions of host cells 
supplied during cellular S phase for their DNA replication (Cotmore.SF and Tattersall.P, 1987). 
 
2.2.3 Virus structure 
 
2.2.3.1 Morphology  
                                                                                                                   
The three dimensional structures of several parvoviruses have been determined to atomic 
resolution by using X-ray crystallography. These studies revealed the presence of (i) spike 
protrusions at the icosahedral threefold axes, (ii) a cylindrical structure surrounded by a canyon 
like depression at about the five fold axes, and (iii) a dimple- like depression at the two fold axes 
(McKenna.R, et al, 1999). The analysis of these structures allowed several functional implications 
to be postulated, in particular regarding tissue tropism, antigenicity and DNA packaging. 
 
2.2.3.2 The virion 
 
The parvovirus virion has a relatively simple structure composed of only three proteins and a 
linear, single-stranded DNA molecule. The particle has icosahedral symmetry and a diameter of 
18 to 26 nm. There are 60 protein subunits, consisting primarily of VP2. The main structural motif 
is 8 stranded β barrel composed of VP2, but much of the protein is present as large loops 
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connecting the strands in the β barrel structure (Kaufmann.B, et al, 2004). The particle has a 
molecular weight of 5.5 to 6.2 x 106. Approximately 50% of the mass protein and the remainder is 
DNA. Because of relatively high DNA-to-protein ratio, the buoyant density of the intact virion in 
CsCl is 1.39 to 1.42 g/cm2. Due to the structurally simplicity, the virion is extremely resistant to 
inactivation. It is stable between pH 3 and 9 and at 56° C for 60 min. The virus can be inactivated 
by formalin, β-propriolactone, hydroxylamine and oxidizing agents (Cotmore.SF and Tattersall.P, 
1987). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of parvovirus capsid. (Reguera.J, et al, 2004):  Thick lines delimit 
1 of the 20 identical trimeric subunits, and the three VP2 subunits within this trimer are numbered 1, 2, and 
3. A ribbon model of the structure of one VP2 subunit has been superimposed. 
 
2.2.3.3 Genome 
 
The genome is a linear, single-stranded poly-deoxynucleotide chain. Several parvovirus DNAs 
have been completely sequenced. H-1 and MVM DNAs contain 5,176 and 5,084 bases. In general, 
autonomous parvoviruses encapsidate primarily strands of one polarity, which is complimentary to 
mRNAs. While AAV encapsidates strands of both polarities with equal frequency.  
 
All parvovirus genomes have palindromic sequences at both the 5’ and 3’ termini of the virion 
strand. The palindromic sequence at the orientation of the 3’ end of the virion strand of the most 
murine autonomous parvovirus DNAs is approximately 115 bases long. In the human parvovirus 
B19, these sequences appear to be more than 300 nucleotides in length. 
 
2.2.3.4 Proteins 
 
NS1 protein acts as a transactivator, covalently bound to a viral DNA, and believed to be release 
during endocytosis. NS2 protein is essential for viral replication and required for sufficient protein 
synthesis. VP1 comprises 15% of virion, and its coding sequence contains all of VP2 plus 140 
additional N-terminal amino acids.VP2, is the predominant capsid protein, accounting for 
approximately 85% of the virion. VP3, a cleavage product of VP2, is present in small, varying 
amounts in DNA- containing virions (Ball-Goodrich.LJ, et al, 2002). VP2 and VP3 constitute the 
majority of capsid proteins in full virions, whereas empty capsids do not contain VP3 (Tattersall. 
P, et al, 1976). 
 
2.2.4 Virus life cycle 
 
The parvovirus H-1 and MVM bind to ubiquitous N- acetylneuraminic acid (sialyl)- containing 
glycoproteins located at the cell surface. So far, the cellular receptors were only identified for the 
human parvovirus B19 and for the related canine and feline parvoviruses (transferring receptor) 
(Brown. KE, et al, 1993 and Parker. JS, et al, 2001). 
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In the nucleus, single-stranded DNA is converted into a duplex replication form, a reaction that 
does not require virus-encoded proteins. This conversion reaction is strictly S-phase dependent, 
and it requires cyclin A and/or associated cdk2 kinase activities that are induced in late G1 and 
early S phases (Bashir.T, et al, 2000). Moreover, conversion was followed by the amplification of 
the duplex intermediate via multimeric forms (Cotmore. SF, et al, 1987). Duplex parvoviral DNA 
serves as a template for the synthesis of mRNAs and progeny single-stranded DNA to be 
packaged into empty capsids form in the nucleolus.  
 
The observation that the mature virion is redistributed from the nucleolus into the nucleoplasm 
suggests that nucleolus function, perhaps cellular chaperon protein(s), is needed for genome 
packaging. Although parvovirus structure and composition are simple, its packaging pattern 
appears to have evolved along with that of adenovirus. The mature MVM virion has one molecule 
of NS1 covalently attached to the 5’ end of the MVM genome, with the NS1 outside of the 
nucleocapsid. 
 
The release of progeny virions of replicated parvovirus is usually associated with cell death. H-1 
virus infection was shown to induce apoptosis in human promonocytic leukemic and 
hepatocellular carcinoma cells, in rat glioblastoma cells, and in the cerebellum of infected rats 
(Rayet. B, et al, 1998 and Moehler. M, et al, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Life cycle of parvoviruses (Bashir.T, et al, 2000). Schematic representation of the cellular 
factors assembled at the MVM virion DNA primer-template junction and thought to be involved in 
complementary strand elongation. Cyclin A or the cyclin A cdk2 complex may regulate the conversion 
reaction by forming part of the elongation machinery and/or phosphorylating some of its constituents. 
 
2.2.5 Genome organization and gene expression 
 
Both ends of the viral genome consist of palindromic sequences that can form hairpin structures 
and serve as self-priming origins of DNA replication (Cotmore.SF, et al, 1987). Most of the 
autonomous parvovirus genome consists of two large open reading frames (ORFs) and two 
promoters (figure 3) (Maxwell.IH, et al, 2002). The left-and right-hand ORFs code for the non-
structural (NS) polypeptides and viral capsid proteins (VP), respectively. 
 
Generally, Parvovirus capsid contains 60 protein subunits, encoded by alternative splicing of 
mRNA. The P38 promotor (at map unit 38) programs R3 transcripts of approximately similar size 
that are generated by differential splicing and encode the capsid proteins (structural proteins) VP1 
and VP2 (Cornelis.JJ, et al, 1990). Overlapping of two transcription units produce three major 
cytoplasmic mRNA species. The transcripts R1 and R2 are both initiated from the left handed 
promoter (P4) at map unit 4 and translated into non-structural proteins NS1 and NS2, respectively.  
The right-hand promoter (P38) directs the transcription of the genes encoding the structural 
proteins. The capsid proteins VP1 and VP2 are translated using two distinct initiation codons as a 
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result of differential splicing of the precursor messenger RNA (Cotmore.SF, et al, 1987).  Most 
abundant protein VP2 comprises the C-terminal 64 kDa region of the 83 kDa VP1. VP2 can be 
processed to VP3 by proteolytic cleavage of approximately 25 amino acids and form it N-
terminus, can be seen only in DNA containing virions (Tattersall.P, et al, 1977). The N-terminal 
domain of VP2 is essential for the nuclear export of full particles. The proteolytic cleavage of VP2 
may occur at the stage of virus binding to the host cells; however, role of VP2 during the virus 
cycle remains unclear. The VP1-specific N-terminal domain is highly basic, contains a number of 
putative nuclear localisation signals (Lombardo.E, et al, 2002) as well as highly conserved PLA2 
domain (Zadori.Z, et al, 2001). This domain is protruded out of the capsid shell without 
disassembly (Cotmore.SF, et al, 1999). The later process might be required for the transport of the 
virions from the late endosomes/lysosomes to the nucleus (Zadori. Z, et al, 2001), explaining why 
capsids devoid of VP1 can be assembled but lack infectivity (Tullis.GE, et al, 1993). The capsid 
VP2 is necessary for capsid formation and packaging of the viral genome (Tullis. GE, et al, 1993 
and Willwand.K, et al, 1993). 
 
The strong left-hand promoter (P4) controls the expression of the NS1 and NS2 polypeptides. NS1 
is a phosphorylated protein that is required for replication of the viral genome after the incoming 
single- stranded DNA has been converted into a duplex form. To exert its replication function in 
the nucleus, NS1 contains a nuclear localization signal and is endowed with helicase, 
endonuclease, ATPase, and site-specific DNA binding activities. Beside its functions in viral 
DNA replication, NS1 is a transcription factor by virtue of its ability to transactivate the P38 
promotor (Rhode.SL III, 1985). Importantly, it was already described that, NS1 exhibit cytotoxic 
properties (Caillet-Fauquet.P, et al, 1990, Li.X and Rhode.SL III, 1990). Thus the lytic outcome of 
a parvovirus infection may be due, at least in part, to the overexpression of this viral protein. 
Phosphorylation of the NS1 polypeptide also plays an important role in this regard, as it was 
shown to control both the replicative and cytotoxic functions of the viral product (Nüesch.JP, et al, 
1998, Corbau.R, et al, 2000). 
 
The small non-structural protein NS2 plays an important role and it is required at various steps of 
the parvoviral life-cycle in a host specific manner (Naeger.LK, et al, 1990). In mouse cells 
infected with MVM mutants unable to express NS2, (i) the synthesis of DNA replication forms 
(RF) severely impaired, (ii) progeny single-stranded DNA is undetectable, and (iii) the VP1 and 
VP2 proteins that are synthesized do not become assembled into capsids (Cotmore.SF, et al, 
1997). NS2 may be non-essential in cells from other species such as the SV40- transformed 
human fibroblasts NBK-324 (Naeger.LK, et al, 1990), even though NS2 may still play a role in 
the release of virions from these cells (Cotmore.SF, et al, 1997). It was also shown that functional 
NS2 is also needed for the efficient nuclear egress of progeny virions, and may therefore 
participate in virus spread (Eichwald.V, et al, 2002). 
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Figure 3: Structure of the LuIII parvovirus genome (Maxwell.IH, et al, 2002). (A) Major mRNAs 
present in infected cells. (B) DNA is single stranded (having both polarities, in contrast with MVM and H-
1), with the termini having hairpin structure. (A) In the infectious plasmid and the replicative form DNA, 
the termini form inverted repeat sequences which contain origins of replication and packaging signals. 
These black bars termini must be retained in gene transfer vectors. P4 promoter is alternatively spliced by 
the primary transcript. (B) The small alternative splices shown just before where the translation of NS1 
terminates. NS2 proteins share an N-terminal amino acid sequence with NS1 but their translation continues, 
followed by the large splice, in a different reading frame and the small splices give rise to C-terminal 
variants of NS2. The p38 promoter, on transactivation by NS1, give rise to a primary transcript that is 
subject to the same alternative small splices, generating the mRNAs for the capsid proteins, VP1 and VP2. 
In the more abundant mRNA, encoding the major protein, VP2, the splice removes the VP1 initiation 
codon, allowing translation to initiate at the appropriate downstream AUG. 
 
2.2.6 Use of parvoviruses in medicines 
 
Several ways of in vitro transformation of human and rodent cells, including viral and cellular 
oncogenes, was found to correlate with an increase in their capacity to sustain certain steps of the 
productive parvovirus (H-1 and MVM) cycle, in particular amplification of DNA, gene expression 
and killing the cells. Parvovirus H-1 exhibit oncotropic nature and thus could be visualized at the 
individual level in human fibroblast cultures. Indeed, the proportion of these cells that were able to 
accumulate nuclear NS1 proteins in amounts detectable by immunostaining were considerably 
higher in transformed than in non-transformed parental cultures. It is noteworthy that normal cells 
take up parvovirus particles as efficiently as their transformed derivatives in the cell systems 
analyzed so far, indicating that in the former virus replication and cytotoxicity are blocked at an 
intracellular step manner (Rommelaere.J, et al, 1991). 
 
Similar findings about oncotropic and oncolytic behaviour of rodent parvoviruses were observed 
by using various cultures of tumor derived cells, as compared with normal cells of the same tissue 
origin (Rommelaere.J, et al, 1991). Therefore, it appears that some cancer cells provide these 
viruses with an environment that are beneficial to their multiplication. This feature was recently 
exploited for the isolation of the new rat parvovirus (RPV-1). Indeed, by implantation tumour cells 
in rats suspected of being parvovirus-infected, a previously unknown parvovirus could be 
recovered from the developing tumors (Ball-goodrich.LJ, et al, 1998). A parallel may be drawn 
between this oncotropism of parvoviruses and their known predilection for highly proliferating 
and generally poorly differentiated cells (Cotmore.SF and Tattersall.P, 1987). Since oncogenic 
transformation is accompanied by cell cycle and differentiation dysregulations (Hanahan.D, et al, 
2000 and Harbour.JW, et al, 2000), it can be assumed that some of these changes are advantage to 
mRNAs 
(A) 
(B) 
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the parvovirus, e.g., by extending the timeframe during S-phase-coupled virus replication and 
expression. 
 
2.2.7 Parvovirus in gene therapy 
 
Replication of parvoviruses do not occur in resting cells, and the permissiveness of cycling cells to 
parvovirus infection is much restricted by their differentiation state, thus the safety of H-1 and 
MVMp-based vectors is expected to be high. (Cotmore.SF and Tattersall.P, 1987). Further, these 
viruses failed to induce significant inflammatory reactions even after repeated injections in animal 
models (Giese.N, et al, 2002). In agreement with this assumption, two phase I clinical studies 
showed no adverse reactions in patients suffering from osteosarcoma or other solid tumors after 
infection with wild-type H-1 virus, despite the fact that virus amplification and seroconversion 
took place in most cases (Toolan.HW, et al, 1965). However, these pilot studies should be 
extended by including more parameters of virus infection and host immune and inflammatory 
reactions (Lang.S, et al, 2002). In particular, potential targets for H-1 virus infection and 
pathogenicity, such as leukocytes (Moehler.M, et al, 2003), endothelial cells and high cell-
turnover tissues, should be evaluated for their susceptibility to parvovirus infection. Cellular 
immune responses triggered by the virus also need to be investigated in infected patients. 
Neutralising antibodies are readily formed after parvovirus infections in animals (Jacoby.RO, et 
al, 1996 and Lang.S, et al, 2002). These antibodies have been shown to reduce the efficiency of 
subsequent therapeutic administrations of wild-type or recombinant viruses, but can be 
circumvented by the further use of pseudotypes in which the virus/vector genome of interest is 
packaged within the capsid of a related parvovirus (Lang.S, et al, 2002). This strategy may be 
applied to humans who also appear to develop neutralizing antibodies against inoculated H-1 virus 
(Lang.S, et al, 2002). 
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2.3 Overview:- Mechanisms of nuclear transport  
 
2.3.1 Endocytosis 
 
Endocytosis is an important process and endocytic entry is an advantangeous pathway for viruses. 
Firstly, the viral particles are directed only into cells that have active membrane transport and not 
into erythrocytes, a dead end. Secondly, a particle can bind anywhere on the cell surface and rely 
on the endocytic processes to ferry it not only into the cell but also to carry the past cortical actin 
filaments and other cytoplasmic barriers to the perinuclear region (Marsh.M and Bron.R, 1997). In 
this process, a virus avoids diffusion through the cytoplasm by itself. Thirdly, penetration from 
cytoplasmic organelles decreases the risk for immunodetection because viral proteins are not 
exposed on the plasma membrane. Fourthly, in the endocytic organelles, local cues such as low 
pH help the virus undergo its penetration programme (Falnes.PO, et al, 2000). 
 
Endocytosis is the essential process used by the cell to internalize the extracellular ligands in 
plasma membrane derived vesicles. Endocytic processes can be occurred by different pathways 
such as lipid-raft-mediated endocytosis, macropinocytosis, calveolae-mediated endocytosis and 
clathrin-mediated endocytosis. Apparently the most common pathway for viral entry in different 
viruses, enveloped and non-enveloped, have been shown to use a clathrin-mediated pathway with 
penetration in early or late endosomes. 
 
Clathrin-mediated endocytosis is the major pathway for selective internalization of plasma 
membrane receptors and the ligands bound to them (Simonsen.A, et al, 2001). A cargo selection 
by clathrin coated vesicles is attributed to endocytic signals present on the cytoplasmic tails of the 
plasma membrane receptors. The binding of the extra cellular ligands to receptors is followed by 
interactions of adaptor proteins (AP2s) and accessory proteins with lipids and receptors. These 
interactions mediate the recruitment of the receptors into the coated areas of plasma membrane 
and cause the clathrin lattice to force vesicle invagination of the membrane. Invaginated pits 
undergo vesicle fission with the help of dynamin (a GTPase) and other effector proteins 
(Marsh.M, 2000). In addition to clathrin-dependent pathway, cells have also other mechanisms to 
internalize (macro) molecules bound to their receptor. For instance macropinocytosis, this is the 
characteristic feature for macrophages and dendritic cells. Many authors have reported that the 
clathrin-independent pathways may integrate with clathrin-dependent pathway (Montesano.R, 
1982, Tran.D, et al, 1987, Vilhardt.F, et al, 1999). Furthermore, in many cases, molecules enter 
cells both by clathrin-dependent and independent routes (Marsh.M, 2000). 
 
Ligands taken into cells by clathrin-mediated endocytosis are transported to early endosomes 
(EEs). Slightly acidic environment (pH 5.9-6.0) in early endosomes causes many ligands to 
dissociate from their receptors (Mukherjee.S, et al, 1997). These receptors contain specific signals 
on their cytoplasmic tail may cause them to be sorted and returned back to the plasma membrane 
for reuse, while others are transported together with dissociated ligands to the lysosomes for the 
degradation (Mellman.I, 1996 and Riezman.H, et al, 1997). Recycled molecules, targeted back to 
the plasma membrane, are rapidly shuttled back to the plasma membrane from EEs or from the 
tubulovesicular compartment near the nucleus, known as recycling endosomes or perinuclear 
recycling endosomes (RE) (Gruenberg.J and Maxfield.FR, 1995). The transitition through RE is 
slow and requires an intact microtubular network. However, early endosomal membranes contain 
the small GTPases Rab4 (Daro.E, et al, 1996), Rab5 (Bucci.C, et al, 1992) and the early 
endosomal antigen-1 (EEA1) as specific marker proteins. These molecules thought to confer 
directionality for endocytic transport (Simonsen.A, et al, 2001). In addition, EEs contain special 
proteins destined for recycling as well as degradation (Yamashiro.DJ, et al, 1984), whereas REs 
have Rab11 and proteins destined specifically for recycling (Yamashiro.DJ, et al, 1984). REs also 
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possess more alkaline pH EEs (Yamashiro.DJ, et al, 1984, Sipe.DM, and Murphy.RF, 1987 and 
Mukherjee.S, et al, 1997). Late endosomes (Les) are considered as an intermediate structure in the 
transport of endocytosed molecules, lysosomal hydrolases and membrane proteins to lysosomes. 
They differ from EEs by their lower luminal pH (pH 5-6), different protein composition and 
association with different small GTPases of the Rab family (Rodman.JS and Wandinger-Ness.A, 
2000). LEs and lysosomes (LYs) have lysosomal membrane proteins (LAMPs or Lgps) associated 
in their membranes and both LEs and LYs have properties expected of functional degradative 
compartments including a low luminal pH and contents of acid hydrolases. Unlike lysosomes, LEs 
are enriched in mannose 6-phosphate receptors (MPRs) (Griffiths.G, et al, 1990, Griffiths.G and 
Gruenberg.J, 1991). In addition, LYs has a slightly lower pH (pH 5-5.5) than LEs (Mukherjee.S, 
et al, 1997). It has been reported that there is also retrograde traffic from terminal lysosomes to 
LEs suggesting dynamic equilibrium between LEs and lysosomes (Jahraus.A, et al, 1994). In 
addition, receptor bound ligands can be transported from clathrin coated pits to ER (Gruenberg.J 
and Maxfield.FR, 1995, Mallard.F, et al, 1998). After binding to its receptors on the cell surface 
toxin-receptor complex is internalized in clathrin coated pits and transported via EEs and REs to 
the trans golgi network (TGN) of the golgi and the finally to the ER (Mallard.M, et al, 1998). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: A schematic cell entry mechanisms utilized by parvoviruses within the host cell is shown 
(Vihinen-Ranta. M, et al, 2004). After binding to their cell surface receptors, viruses are internalized into 
clathrin-coated vesicles (CV), followed by transport to early (EE), late (LE), or perinuclear recycling 
endosomes (PNRE). Later in entry, in the case of AAV, capsids are found in golgi compartments, whereas 
CPV can be found in lysosomes (LY). The site of the capsid escape from endocytic vesicles into the cytosol 
is still unclear. CPVs make use of microtubules (MT) during the traffic through the cytosol toward the 
nucleus. Viral capsids are able to enter the nucleus in intact form without apparent deformation. 
 
Although the receptor-ligand complex has a certain intracellular multivalent ligands such as 
multivalent transferrin (composed of more than 10 transferrin molecules) may result redirecting of 
a ligand-receptor complex. Transferrin is transported to the REs and receptor-bound multivalent 
transferrin is rerouted to the degradative pathway. In addition, apo-B, E-receptor (Tabas.I, et al, 
1990, 1991), M glycoprotein (as coronavirus receptor) and Fc-receptors (Mellman.I and Plutner.H, 
1984) have also reported to be rerouted by the binding of multivalent ligands. All in all, the basic 
organisation of the endocytic pathway has been elucidated, particularly in the case of the 
internalization of protein ligands bound to the cell surface receptors (Kornfeld.S and Mellman.I, 
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1989, Trowbridge.IS, et al, 1993, Gruenberg.J and Maxfield.FR, 1995, Mellman.I, 1996), there 
remains much to be studied to fully understand the complex processes of the endocytosis. 
 
During recent years, lipids found to contribute to the organization and functions of the vacuolar 
system (Gruenberg.J, 2001). The membrane phospholipids phosphatidylinositol can be 
phosphorylated in different ways to produce distinct second messengers known as 
phosphoinositides. Localised changes of phosphoinositides are mediated by kinases and 
phosphatases providing temporal and spatial regulation of the membrane budding, motility and 
fusion (Simonsen.A, et al, 2001). Phosphoinoitides seem to be rather well organized the organelles 
of the endocytic pathways (Gruenberg.J, 2001). Clathrin coated vesicle (CCVs) are enriched in 
phosphatidylinositol 4, 5-phosphates (PI (4, 5) P2), that seems to have the key role of regulating 
formation, scission and uncoating of CCVs (Jost.M, et al, 1998). Phosphoinoitides, in particular 
(PI 4, 5) P2 and phosphatic acid, have been reported to participate in CCV formation as regulators 
of dynamin membrane activity (Lin.FT, et al, 1997, Burger.KN, et al, 2000). Phosphatidylinositol 
3-phosphate, which interacts with proteins containing a FYVE or PX domain, is concentrated in 
early endosomal membranes, where it is suggested to regulate the fusion events of EEs through 
Rab5-GTP (Simonsen.A, et al, 1998, Gillooly et al, 2000, Rubino.M, et al, 2000, Simonsen.A, et 
al, 2001). Furthermore, lysophosphatidic acid and phosphatidylinositol 3, 5-bi phosphate (PI (3,5) 
P2) are suggested to be typical lipids for endosomal carrier vesicles, multi vesicular bodies and late 
endosomes (Shisheva.A, et al, 2001), while sphingolipids and sulfatide are abundant in recycling 
endosomes (Holtta-Vuori.M, et al, 2002). However, the roles of these lipids on membrane 
trafficking have not yet been clarified. 
 
2.3.2 Acidification 
 
Acidification is an important property for endocytic sorting. One of the major functions of 
endosomes is to dissociate ligands from their receptors. After dissociation, many receptors are 
recycled to the cell surface and the ligands are degraded (Davis.CG, et al, 1987, DiPaola.M and 
Maxfield. FR, 1984). Receptors release their ligands at low pH could result from a pH- dependent 
conformational change in the receptors. This was also demonstrated for the EGF and the 
asialoglycoprotein receptors (DiPaola.M, et al, 1984). Additionally, neutralizing the endosomal 
pH with the proton ionophore monensin prevents ligand-receptor dissociation (Kaiser.J, et al, 
1988, Nunez.MT and Glass.J, 1985). A separate function that is also a consequence of pH-
dependent conformational change is the release of iron from transferring. Sorting of endosomes at 
the acidic pH, iron is released from transferrin, and apo-transferrin remains bound to its receptors 
in the acidic endosomes. (Dautry-Varsat.A, et al and 1983, Rao.K, et al, 1983). 
 
Endosomal acidity is maintained by ATP-dependent proton pump (vacuolar H+ ATPase), which is 
a member of a family of multi-subunit proton pumps (AL-Awqati.Q, 1986, Gluck.SL, 1993, 
Nelson.N, 1987). This family includes the proton pump in adrenal chromaffin granules and other 
secretory vesicles and is similar to proton pumps in the membranes of plant vacuoles. These 
proton pumps are electrogenic in that the movement of a proton results in translocation of the net 
charge that is not directly coupled with the transport of another ion to maintain electroneutrality. 
The mechanism for maintaining the different acidities in endosomes is not certain, although 
several hypotheses have been put forth. Early endosomes, but not late endosomes, contain the 
Na+-K+-ATPase (Cain.CC, et al, 1989, Fuchs.R, et al, 1989, vanWeert.AW, et al, 1995). The Na+-
K+-ATPase would generate an inside positive membrane potential that would make it more 
difficult to pump protons into the endosome. Its presence in early sorting endosomes thought to be 
required for their relatively low acidification (Sato.SB and Toyama.S, 1994). Other ion 
transporters such as chloride channels may also affect and regulate the pH of endosomes (AL- 
Awqati.Q, 1986, Nelson.N, 1987). A suggested mechanism by which changes in the membrane 
14 
potential can affect the steady-state pH of an endosome involves changes in the coupling between 
proton translocation and ATP hydrolysis by the vacuolar proton pump as the proton concentration 
and or positive charge in the compartment builds up (Nelson.N, 1987). 
 
The control of the internal pH of endosomes plays an important role in membrane traffic. For 
example, inhibition of the vacuolar H+-ATPase causes slows delivery to late endosomes or 
lysosomes in different cell types (Clague.MJ, et al, 1994 and van Weert.AW, et al, 1995), and it 
slows receptor recycling in CHO cells (Johnson.LS, et al, 1993). Similarly, the movement of 
TGN38 along the endocytic pathway was inhibited after neutralization of the endosomal pH 
(Chapman.RE and Munro.S, 1994). However, the mechanisms by which internal pH alter 
properties such as the maturation of endosomes or the rate of recycling remains unclear. The 
problem is that most of the affected properties require changes on the cytoplasmic side of the 
vesicle. One possibility is that pH-induced conformational changes in the luminal domains to 
transmembrane proteins are transmitted across the membrane and affect the cytoplasmic domain. 
Many receptors and other membrane proteins have been shown to have pH-dependent 
conformational changes over the range from pH 5 to 7 (Diapola.M and Maxfield.FR, 1984, 
Turkewitz.AP, et al, 1988), including changes in their ability to self-associate (Turkewitz.AP, et 
al, 1988). For asialoglycoprotein receptor, biophysical studies have shown that changes in pH or 
transmembrane electrical potential can cause gross changes in the disposition of the protein in the 
bilayer (Blumenthal.R, et al, 1983 and Blumenthal.R, et al, 1980). 
 
The mechanisms of viral entry of non-enveloped viruses into the cytoplasm and nuclear targeting 
of the virus or its genome prior to replication are still poorly understood. However, the use of 
certain members of the parvovirus family as vectors for gene therapy has prompted research in this 
field. A common uptake principle of these viruses involves receptor-mediated endocytosis. 
However, cell surface attachment differs among parvoviruses. Authors reported that, MVM and 
parvovirus H-1 use sialic acid moieties of cell surface glycoproteins as the receptor (Cotmore.SF, 
and Tattersall.P, 1987). Canine parvoviruses (CPV) and feline parvoviruses use the transferrin 
receptor (Parker.JS, et al, 2001). For B19, one glycolipid, globotetraosylceramide or globocide is 
the receptor (Brown.KE, et al, 1993, Chipman.PR, et al, 1996). Bovine parvovirus binds to sialated 
erythrocyte membrane glycoproteins and attaches to the major membrane glyprotein, glycophorin 
A (Thacker.TC, and Johnson.FB, 1998). Adeno-associated viruses (AAVs), of the Dependovirus 
genus of parvoviruses, were reported to employ membrane-associated heparan sulfate 
proteoglycans as cellular receptors (AAV-2) (Summerford.C and Samulski.RJ, 1998) or sialic acid 
(AAV-4 and -5) (Kaludov.N, et al, 2001 and Walters.RW, et al, 2001). Acidification is known to 
be essential for the entry of AAV and CPV, since drugs that interfere with the endosomal pH are 
able to block the infection (Bartlett.JS, et al, 2000, Basak.S and Turner.H, 1992, Douar.AM, et al, 
2001, Parker.JS and Parrish.CR, 2000, Vihinen-Ranta.M, et al, 1998). The infectious entry of CPV 
could also be blocked by the disruption of microtubules and by low temperatures, suggesting the 
involvement of microtubule dependent transport (Vihinen-Ranta.M, Kalela.A, et al, 1998). For 
AAV translocation to the nucleus, functional microtubules and microfilaments are needed 
(Sanlioglu.S, et al, 2000). The release of these viruses may be directly linked to the acidification of 
the vesicle. However, the exact mechanism and time course of this release from the endosomal 
compartments remain unclear. Sequence analysis of the VP1 revealed phospholipase A2 motifs in 
the capsid proteins of parvoviruses, an activity that was not known to exist in viruses and that 
might be responsible for parvovirus entry (Dorsch.S, et al, 2002, Li.Y, et al, 2001, Zadori.Z, et al, 
2001). However, the mechanism and time course by which the viral particles, once released into 
the cytoplasm, translocate to the nucleus is not known. 
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2.3.3 Signal- mediated nuclear import 
 
The nucleus and cytoplasm are separated by the double membrane of the nuclear envelope. The 
outer membrane is continuously connected with the membrane of the endoplasmic reticulum. 
Transport between the cytoplasm and the nucleoplasm is highly regulated and occurs through 
protein-lined aqueous channels called nuclear pore complexes.  
 
The NPC physically allows for the signal-mediated passage of large, charged molecules across the 
nuclear envelope. Theoretically, proteins could transverse back and forth across the nuclear 
envelope but be specifically retained in the nucleus by a nuclear retention signal. Alternatively, 
trafficking across the nuclear envelope could be restricted to those proteins that carry an NLS to 
target them for active nuclear import. The first NLS identified was a basic stretch of amino acids 
(KKKRK) from the SV40 large T-antigen. This sequence has been named the classical NLS. A 
second class of NLS, the bipartite signal, is characterized by the sequence from the Xenopus 
nucleoplasmin protein in which the classical NLS is broken into two halves by an intervening 
group of 5 to 20 amino acids (KRPAATKKAGQAKKKK). The hnRNP A1 proteins contain a 
third class of NLS, termed the M9 sequence. Unlike the other NLSs, M9 is not rich in basic amino 
acids, but functions as both a nuclear import and export signals. 
 
2.3.4 The Nuclear Pore Complex (NPC) 
 
 
          
 
Figure 5: Structure of the nuclear pore complex (Hinshaw.JE, et al, 1992, Pante.N and Aebi.U, 1996). 
(A) A 3-D reconstruction of detergent extracted and negatively stained nuclear pore complexes, revealing 
the central framework which exhibits strong 822 symmetry and thus consists of two identical halves relative 
to the central plane of the nuclear envelope (NE). (B) Higher eukaryotic NPC, based on electron 
microscopic structural studies. The symmetrical membrane-spanning portion contains an aqueous, possibly 
gated, central channel through which translocation occurs, and a central plug of unclear composition and 
function. The cytoplasmic filaments and nuclear basket are involved in the initial and terminal stages of 
translocation. The location of some nucleoporins (nups) as determined by electron microscopy, are 
indicated. 
 
In vertebrates, the NPC is a large 125 MDa multiprotein structure that completely spans across the 
nuclear envelope (NE) and extends into cytoplasm and nucleoplasm. It contains about 30 different 
proteins that are present in at least 8 fold redundancies. The NPC consists of a membrane-
embedded framework (the spoke complex), which is formed by 8 multidomain spokes with two 
rings on each face (Figure 5). The ring facing the cytoplasm is connected with eight 50 nm long 
fibrils extending into the cytoplasm. The nuclear ring is capped with a basket like assembly of 
eight thin, 50-100 nm filaments joined distally by a 30-40 nm diameter terminal ring. The centre 
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of the channel harbours a hydrophobic framework through which the signal-mediated bi-
directional transport of macromolecules occurs. The proteins that form the NPC are called 
nucleoporins (nups). Nucleoporins have been localised to discrete regions of the NPC and are 
often used as markers for this compartment. Approximately half of the nucleoporins contain a 
phenylalanine-glycine repeat motif (FG repeat) which play an important role in the nuclear 
transport of protein. During each cell division, higher eukaryotes go through an open mitosis 
characterized by dissolution of the nuclear envelope. In a coordinate fashion, the NPC is also 
disassembled. Notably, some nups play important roles during or after mitotic remodeling of the 
pore itself (Salina.D, et al, 2003). 
 
2.3.5 Nuclear localisation signal (NLS) receptors and import factor recycling 
 
Nuclear import of NLS-containing proteins is mediated by a family of transport molecules 
collectively known as karyopherins or importins. Proteins with the classical NLS present in the 
cytoplasm are bound by importin α, which recognizes the highly basic PKKKRV amino acids 
(Nadler.SG, et al, 1997). Importin α acts as an adaptor molecule, binding both the NLS of the 
cargo protein and via its importin β binding domain (IBB) to importin β. Nucleoplasmin and other 
proteins with a bipartite NLS use the same importin α/β import machinery. It was later discovered 
that β homologoues can directly bind to various IBB -like domains (Lange.A, et al, 2007). These 
α/β/NLS or β/NLS multiprotein complexes localize to the NE as importin β binds to cytoplasmic 
fibres that protrude from the NPC (Gorlich.D, et al, 1996). Dissociation occurs via Ran GTP, once 
the import complex reaches the nucleus. Binding of Ran GTP to importin β causes a 
confirmational change that result in the release of the importin α-cargo complex (Lee.SJ, et al, 
2005 and Weis.K, et al, 1996). The importin β binding (IBB) domain of importin α (Kobe.B, 
1999), nucleoporin nup2 (nup 50 or Npap 60 in vertebrates) (Gilchrist.D, et al, 2002, Matsuura.Y, 
et al, 2003, Matsuura.Y and Stewart.M, 2005) and the export receptor for importin α, Cse1/Ran 
GTP (CAS/Ran GTP in vertebrates) (Matsuura.Y and Stewart.M, 2004) then work together to 
deliver the cargo into the nucleus. Finally, Cse1/RanGTP recycles importin α back to the 
cytoplasm to repeat another round of import (Hood.JK and Silver.PA, 1998, Kutay.U, et al, 1997). 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The classical nuclear import cycle (Lange.A, et al, 2007). In the cytoplasm, cargo containing 
NLS bound by the import receptor, importin α/β. Importin α recognises the NLS, and the importin β 
mediates interaction with the nuclear pore during translocation. Inside the nucleus, RanGTP binding causes 
a conformational change in importin β, which release the IBB region of importin α. This domain, 
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nucleoporin and Cse1, facilitates the NLS dissociation and the delivery of the NLS cargo in the nucleus. At 
last, importin α recycles back to the cytoplasm to take for another round of import. 
 
2.3.6 Nuclear envelope (NE) and  nuclear envelope breakdown (NEBD) 
 
In eukaryotic cells, NE (nuclear envelope) separates the nucleoplasmic and cytoplasmic activities. 
The NE is mainly composed of two lipid bilayer membranes: 1) Outer nuclear membrane (ONM) 
2) inner nuclear membrane (INM). Outer nuclear membrane is continuous with the endoplasmic 
reticulum (ER), decorated with ribosomes and is a site for protein translation and modifications. 
The ONM and the inner nuclear membrane (INM) are separated by a 25-45 nm thick lumen and 
are fused at sites where the nuclear pore complexes (NPC) are embedded. Underlying the INM 
and bordering the peripheral chromatin, there is a protein meshwork called the nuclear lamina 
(Gruenbaum.Y, et al, 2005). 
 
Key events in the early stages of mitosis in metazoans are hallmarked by nuclear envelope 
breakdown (NEBD) and release of condensed chromosomes into the cytoplasm. NEBD involves 
the disassembly of all major structural elements of the nuclear envelope, including nuclear pore 
complexes (NPCs), and the dispersal of nuclear membranes components. In NEBD, minus-end 
directed motion started to create pulling force on the NE surface towards the centrosome. These 
forces become stronger with increasing length and number of spindle microtubules and push NE 
materials towards to centrosomes, creating folds. Distal from centrosome, creates stretching and 
disruption of nuclear lamina. After NEBD, NE fragments pulled away from chromosomes by 
dynein. In this model NEBD is caused by tearing a nuclear lamina, which is shown to correspond 
the site of permeabilization (Beaudouin.J, et al, 2002). 
 
2.3.6.1 Mitosis  
 
The NE (nuclear envelope) completely disassembles during mitosis in a process called “open 
mitosis in higher eukaryotes”. Nuclear membranes, nuclear lamina, and NPCs disassemble 
between prophase and prometaphase stages of the cell cycle allowing engagement of the 
chromosomes with the cytoplasmic mitotic spindle. The dynamics of NE are best examplified, 
when nuclear membranes disassemble from chromatin and the break down of nuclear lamina. 
Irrespective of whether lamins, integral proteins of the INM, NPC proteins or all of these play 
important roles in driving the disassembly of NE at mitosis, it is generally agreed that their cell 
cycle-dependent phosphorylation is critical in these processes. Many authors reported that several 
integral proteins of the INM, including LBR (Lamin B receptor), LAP2β (Lamin associated 
proteins) and emerin, are also phosphorylated at mitosis (Courvalin.JC, et al, 1992, Ellis.JA, et al, 
1998, Foisner.R and Gerace.L, 1993, Dreger.M, et al, 1999). In contrast to lamins, however, there 
is no evidence for a role and involvement of multiple kinases in phosphorylation of INM integral 
proteins. In addition, specific residues phosphorylated by CDK1 have been identified for LBR in 
the N-terminal nucleoplasmic domain (Courvalin.JC, et al, 1992, Ellis.JA, et al, 1998, Foisner.R 
and Gerace.L, 1993, Nikolakaki.E, et al, 1997). Nucleoporins are also phosphorylated in a cell-
cycle-dependent manner (Favreau.C, et al, 1996), as are chromatin protein HP1 variants, which 
are ligands for LBR (Minc.E, et al, 1999). This suggests the detachment of the INM from 
peripheral structures may result from phosphorylation of a large number of integral and peripheral 
proteins of NE. From in vivo and in vitro studies performed in mammalian somatic cells and in 
Xenopus eggs, it appears that protein kinases promote membrane release from chromatin 
(Foisner.R and Gerace.L, 1993, Pfaller.R and Newport.JW, 1995, Pyrpasopoulou.A, et al, 1996), 
whereas protein phosphatases stimulate binding (Pfaller.R, et al, 1991, Vigers.GP and Lohka.MJ, 
1992). When disassembled, membranes containing LBR, LAP2β and gp210 are excluded from the 
mitotic spindle, suggesting that they are contained in membrane sheets too large to enter the 
microtubule network (Buendia.B and Courvalin.JC, 1997, Chaudhary.N and Courvalin.JC, 1993). 
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Therefore, except for a fraction of emerin which is apparently localised within the spindle 
(Dabauvalle.MC, et al, 1999, Haraguchi.T, et al, 2000), chromosomes and membranes are 
segregated during metaphase inside and outside of the spindle, respectively. 
 
Caspase activation is required for T cell proliferation (Kennedy.NJ, et al, 1999) and that activated 
caspases can cleave the substrates in the non-apoptotic cells during T lymphocyte stimulation 
(Alam.A, et al, 1999). Current study showed caspase 3 is upregulated and activated during the 
G2/M transition. At present, it is not known how caspase 3 participates in the network of the 
mitotic checkpoint. Nevertheless, the pre-activated caspase 3 may enable the system to response 
rapidly when cells were seriously damaged (Hsu.SL, et al, 2006). 
 
2.3.6.2 Apoptosis  
 
Apoptosis or programmed cell death, results in several morphological changes in cell. In addition 
to cytoskeletal alterations and plasma membrane blebbing, the nucleus undergoes remarkable 
remodelling during apoptosis. Chromatin condensation and fragmentation of nuclei were also 
reported (Strasser.A, et al, 2000). Underlying the hallmark changes in morphology and cell 
function is a cascade of proteases, termed caspases. Caspases undermine normal elements of cell 
structure by targeting specific proteins for cleavage (Strasser.A, et al, 2000). Active phase of 
apoptosis is characterized by nuclear modification i.e chromatin condensation (Wyllie.AH, et al, 
1980). This process is secondary to DNA cleavage (Enari.M, et al, 1998 and Sakahira.H, et al, 
1998) and to proteolysis of some specific nuclear proteins by proteases of the caspase family that 
are selectively activated during apoptosis (Thornberry.NA and Lazebnik.Y, 1998, Villa.P, et al, 
1997). In contrast to the precocity of chromatin condensation, nuclear envelope (NE) ultrastructure 
is preserved until the late stages of apoptosis (Wyllie.AH, et al, 1980), despite the early cleavage of 
A-type and B-type lamins, the major peripheral proteins of the envelope (Lazebnik.YA, et al, 1993, 
Weaver.VM, et al, 1996). The dramatic changes in nuclear periphery – including nuclear pore 
clustering (Buendia.B, et al, 1999, Falcieri.E, et al, 1994) as well as the importance of 
nucleocytoplasmic trafficking during apoptosis. 
 
Molecular properties of caspases    
 
Caspases are the interleukin-1β-converting enzyme family proteases, are highly homologous to 
Caenorhabditis elegans cell death gene CED-3. So far, fourteen caspases have been identified and 
all of which share some common properties. All Caspases are aspartate-specific cysteine 
proteases, by having a conservative pentapeptide active site ‘QACXG’ (X can be R, Q or D). 
Additionally, their precursors are all zymogens known as procaspases. The N-terminal of the 
prodomain in procaspases contains highly diverse structure required for caspases activation; and 
they all are capable of autoactivating as well as activation of other caspases, to produce a 
heterodimer with a big and small subunit, and two heterodimers form and enzymatic active 
heterotetramer (Launay.S, et al, 2005), caspases are divided into three subfamilies basing on their 
homology in amino acids sequences, as shown in table below (Fan.TJ, et al, 2005). 
 
Subfamily          Role                               Members 
 
                    I                 Apoptosis activator         Caspase-2 
                            Caspase-8 
                                                                              Caspase-9 
                                                     Caspase-10 
                   II                Apoptosis executioner     Caspase-3 
                                          Caspase-6 
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                                         Caspase-7 
                  III                Inflammatory mediator   Caspase-1 
                              Caspase-4 
                                                                             Caspase-5 
                                                                             Caspase-11 
                                                                             Caspase-12 
                                                                             Caspase-13 
                                                                             Caspase-14 
 
Table : Subfamily members of caspase family 
 
At least 14 caspases have been identified in mammals (Alnemri.ES, et al, 1996, Kumar.S and 
Lavin.MF, 1996, Nicholson.DW and Thornberry.NA, 1997) (figure 7). These enzymes recognize 
tetrapeptide motifs and cleave their substrates on the carboxyl side of an aspartate residue. 
Individual caspases have distinct substrate specificities that are determined by the pattern of amino 
acids upstream of the cleavage site (the P2–P4 positions) (Nicholson.DW and Thornberry NA, 
1997). Caspases are synthesized as zymogens, which have very low intrinsic enzymatic activity. 
The fully active enzymes are heterotetramers composed of two identical subunits of 20 kDa plus 
two identical subunits of 10 kDa (Walker.NP, et al, 1994, Wilson.KP, et al, 1994, Rotonda.J, et al, 
1996). These sub-units can be produced by caspase-mediated cleavage. There is evidence that 
aggregation of at least some caspase zymogens is sufficient to promote self-processing (Muzio.M, 
et al, 1998, Martin.DA, et al, 1998, Srinivasula.SM, et al, 1998).  So called initiator caspases (e.g. 
caspase-8 and caspase-9) start an increasing of caspase activity by processing and activating so-
called effector caspases (Nicholson.DW and Thornberry.NA, 1997). However, some caspases, 
particularly effector caspases, cleave and inactivate certain vital cellular proteins, such as DNA 
repair enzymes, lamin, gelsolin, MDM2 (an inhibitor of p53), and protein kinase C δ 
(Thornberry.NA and Lazebnik.Y, 1998, Nicholson.DW and Thornberry.NA, 1997). There are also 
enzymes that can be activated directly or indirectly by caspase-mediated proteolysis. Certain 
caspases (e.g. caspase-3) can remove a negative regulatory domain from the kinase p21-activated 
protein kinase 2, and this is thought to trigger plasma membrane blebbing (Rudel.T and 
Bokoch.GM, 1997). The caspase-activated DNase (CAD) is normally inactivated by binding to an 
inhibitor, iCAD (also called DNA fragmentation factor (DFF) (Enari.M, et al, 1998, Sakahira.H, et 
al, 1998). During apoptosis, iCAD is cleaved by caspases, and this leads to release of the active 
endonuclease, which produces the characteristic internucleosomal DNA cleavage. 
 
Caspase-3, a key factor in apoptosis execution, is the active form of procaspases-3. The latter can 
be activated by caspases-3, caspases-8, caspases-9, caspase-10, CPP32 (32kDa cysteine protease) 
activating protease, granzyme B (Gran B), and others (Yuan.CQ, et al, 2005). minocycline inhibits 
the proliferation of microglial cells and NMDAR (N-methyl-D aspartate induced activation of p38 
mitogen-activated protein kinase, inhibition of caspase1 and 3 and the inducible form of nitric 
oxide synthase and a decrease in mitochondrial permeability transition mediated cytochrome C 
release (Baptiste.DC, et al, 2004). Through alternative splicing, caspases-3 pre-mRNA can be 
translated into a short caspases-3 (caspases-3S), which lacks the conservative ‘QACXG’ sequence 
in the catalyzing site, and is co-expressed with caspases-3 in all human tissues, overexpression of 
caspases-3S could protect cells from apoptosis induced by proteosome inhibition was observed in 
HEK293 cells (Yuan.CQ, et al, 2005).  Experiments performed by using electrospray MS and N-
terminal sequence analysis revealed the active enzyme site composed of two subunits of 17 kDa 
and 12 kDa, derived from the precursor protein by cleavage at Asp-28-ser-29 and Asp-175-Ser-
176 (Nicholson.DW, et al, 1995). While the initial cleavage is probably between the large and 
small subunits, it has been suggested that processing with in the prodomain occurs initially at Asp-
9, not at Asp-28 (Fernandes-Alnemri.T, et al, 1996, Srinivasula.SM, et al, 1996). 
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Figure 7: Structural comparison of the caspase pro-enzymes and substrate specificity of the caspases 
(Strasser.A, et al, 2000). The aspartate cleavage sites between the large (open bars) and small (tinted bars) 
subunits are indicated. **, Aspartate cleavage site is not known. Death effector domains (DED) and caspase 
recruitment domains (CARD) are shown. Human caspases 1–10, mouse caspases 11–14, and C. elegans 
Ced-3 are shown. 
 
Apoptosis induced in cultured cells or in cell-free extracts generates stereotyped NE alterations. 
These alterations include budding, detachment of membranes from chromatin and clustering of 
NPCs (Lazebnik.YA, et al, 1993, Rao.L, et al, 1996, Buendia.B, et al, 1999). Despite these NE 
alterations, the NE persists and in vivo and in vitro until the late stages of apoptosis, and the 
ultrastructure of chromatin-detached nuclear membranes and NPCs is conserved (Buendia.B, et al, 
1999, Falcieri.E, et al, 1994). First biochemical modification was observed at the NE after 
apoptosis induction was the cleavage of lamins 1-3 h (Rao. L, et al, 1996, Buendia. B, et al, 1999, 
Oberhammer. FA, et al, 1994, Neamati.N, et al, 1995). The  caspases 6 cleavage site of A- and B- 
type lamins has been mapped to a conserved aspartic residue located in a hinge region upstream of 
coil 2 (Rao.L, et al, 1996, Neamati.N, et al, 1995, Orth.K, et al, 1996, Lazebnik.YA, et al, 1995). 
This cleavage generates a carboxy-terminal proteolytic fragment of 46 kDa containing coil 2, 
which is necessary for the formation of stable B-type lamin homodimers and for their lateral 
interactions in filaments. The feature of this proteolytic fragment may explain the persistent 
association of lamina remnants with nuclear membranes until late stages of apoptosis 
(Weaver.VM, et al, 1996, Duband-Goulet.I, et al, 1998). In addition to lamins, other proteins of 
the INM and NPCs are also selectively cleaved during apoptosis, although with a short delay (~ 1 
h) compared with lamin B.  
 
Major nuclear changes occurring simultaneously with NE alterations during apoptosis are 
chromatin condensation and DNA cleavage. Downstream pathway of the effector caspases 3 are 
responsible for oligonucleosomal DNA cleavage (Enari.M, et al, 1998) and chromatin 
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condensation (Sahara.S, et al, 1999), although some factors may also induce peripheral chromatin 
condensation in a caspase-independent manner (Susin.SA, et al, 2000). Chromosome condensation 
is independently facilitated by the loss of integrity of the nuclear matrix secondary to the cleavage 
of some of its components such as NuMA, topoisomerase II, and SnRNP and hnRNP proteins. 
Chromatin condensation process is enhanced by cleavage of lamina network and nucleoporin 
filaments, which are integral parts of the nuclear skeleton. 
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3. Aim of the project 
 
 
The aim of the project is to evaluate the nuclear entry pathway of parvovirus H-1. Firstly, we 
evaluated the homology results obtained from the published data of the minute virus of mice 
(MVM) and the canine parvovirus (CPV). The incoherent of the reported unclear import 
pathways focussed the research in this thesis to search for the mechanisms that are unrelated to 
the previously assumed classical import pathways. 
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4. Material and Methods 
 
4.1 Materials 
 
4.1.1 Antibiotics, Chemicals and Enzymes 
 
Agarose       Amersham (Freiburg)  
Anamed gels (10-20% Tris glycine gels)  Apelex (Massy-France) 
ATP       Roche (Mannheim) 
Bovine serum albumin    Sigma-Aldrich (Taufenkirchen) 
Collagen      BD Biosciences (Heidelberg) 
Creatine phosphate     CalBiochem (Damstadt) 
Creatine phosphokinase    CalBiochem (Damstadt) 
DABCO (1,4-Diazabicyclo-(2.2.2) octane  Sigma-Aldrich (Steinheim) 
Digitonin      Fluka Biochemika (Taufenkirchen)  
DTT       Sigma-Aldrich (Taufenkirchen) 
EDTA       Sigma-Aldrich (Taufenkirchen) 
EGTA       Sigma-Aldrich (Taufenkirchen) 
Fetal calf seurm     GIBCO-BRL (Karlsruhe) 
FITC-Albumin      Sigma-Aldrich (Taufenkirchen) 
Gentamycin      GIBCO (Invitrogen) 
G-418       GIBCO (Invitrogen) 
Glycerin       Merck (Damstadt) 
Lectin from Triticum vulgaris (WGA)  Sigma-Aldrich (Taufenkirchen) 
Moviol      Sigma-Aldrich (Taufenkirchen) 
Nonindet P-40 (NP-40)    Fluka (Buchs) 
Normal goat serum      JI- Research, Dianova (Hamburg) 
Nupage bis-tris gel (4-12%)    Invitrogen (Karlsruhe) 
Nupage tris-acetate gel (4-8%)   Invitrogen (Karlsruhe) 
Optiprep density gradient medium   Sigma- Aldrich (Taufenkirchen) 
Paraformaldehyde     Merck (Damstadt) 
Phenol       Roth (Karshule) 
Phenol red      Merck (Damstadt) 
PLA2 enzyme      Sigma-Aldrich (Taufenkirchen) 
Propidium iodide     Sigma-Aldrich (Taufenkirchen) 
Proteinase K      Roche (Mannheim) 
Rabbit reticulate lysate    Promega (Mannheim) 
Radiochemicals     Amersham (Braunschweig) 
S7 nuclease      Roche (Mannheim)  
TritonX-100       Serva (Heidelberg 
t-RNA (S. cerevisiae)     Sigma-Aldrich (Taufenkirchen) 
Tryphane blue                 Feinbiochemika (Heidelberg) 
Trypsin 10X      GIBCO-BRL (Karlsruhe) 
Tween 20      Merck (Damstadt) 
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4.1.2 Inhibitors 
 
AACOCF3      Merck Biosciences (Damstadt) 
Cycloheximide     Sigma-Aldrich (Taufenkirchen)  
H-89 dihydrochloride     Calbiochem Merck (Damstadt) 
Hygromycin B     Sigma-Aldrich (Taufenkirchen)  
Manoalide      Mol.Bio.Tech  (Gottingen)  
Roscovitine       Sigma-Aldrich (Taufenkirchen) 
Z-VAD-FMK      A.G Scientific (Göttingen)  
(Z-Val-Ala-DL-Asp-fluoromethylketone) 
 
4.1.3 Antibodies and Beads  
 
Alexa fluor 594 donkey anti-mouse   Molecular probes (Heidelberg)  
Alexa fluor 488 donkey anti-rabbit    Molecular probes (Heidelberg) 
Antibody against NS1 anti-mouse Kind gift from Jan Cornelis,   
                                                                                  DKFZ, Heidelberg 
Cy5- conjugated goat anti-mouse   Dianova (Hamburg) 
Cy5- conjugated goat anti-rabbit   Dianova (Hamburg) 
FITC-conjugated goat anti-mouse   Dianova (Hamburg) 
FITC-conjugated goat anti-rabbit   Dianova (Hamburg) 
Karyopherin α/Rch-1 anti-mouse   BD Biosciences (Heidelberg) 
Monoclonal Ab against NPC anti-mouse  Hiss Diagnostic (Freiberg) 
Antibody against VP1 anti-rabbit Kind gift from Jan Cornelis,     
                                                           DKFZ, Heidelberg 
POD-conjugated donkey anti-mouse       Dianova (Hamburg) 
POD-conjugated donkey anti-rabbit   Dianova (Hamburg) 
Texas red-conjugated goat anti-mouse  Dianova (Hamburg) 
Texas red-conjugated goat anti-rabbit  Dianova (Hamburg) 
Dynabeads M280 sheep anti-mouse   Dynal Biotech (Hamburg) 
Dynabeads M280 sheep anti-rabbit   Dynal Biotech (Hamburg) 
 
4.1.4 Cell Lines 
 
EYFP-Lamin B receptor cell line  Kind gift from Jan Ellenberg, EMBL,      
Heidelberg, Germany. (Ellenberg.J, et al, 1997)
     
HeLa cell line Human cervical carcinoma cell line with 
epithelial morphology. The original HeLa cells 
came from Henrietta Varnish, died in 1951 in 
Baltimore, USA.   
           
Huh-7 cell line  Human Hepatoma cell line, established from a 
hepatocellular carcinoma of 57 year old 
Japanese. 
 
NBK cell line  Simian virus 40-transformed human newborn 
kidney cells (Shein and Enders 1962)  
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4.1.5 Primers 
 
H-1 3479f The 5' and 3' end of the primers correspond      TIB MOLBIOL, Berlin                          
the positions (5'-3') 3479-3485 in the genome                                                 
of parvovirus H-1  
  
H-1 3732r The 5' and 3' end of the primers correspond      TIB MOLBIOL, Berlin                          
the positions (5'-3') 3732-3707 in the genome                                                 
of parvovirus H-1  
  
H-1 3´FL Probe The 5' and 3' end of the Hy- probe correspond   TIB MOLBIOL, Berlin                         
the positions (5'-3') 3642-3669 in the genome                                                 
of parvovirus H-1  
 
H-1 3´LC Probe The 5' and 3' end of the Hy- probe correspond   TIB MOLBIOL, Berlin                         
the positions (5'-3') 3671-3698 in the genome                                                 
of parvovirus H-1  
 
4.1.6 Plasmid 
 
H-1 Plasmid (5176+2686bp) Plasmid coding for the Parvovirus H-1 cloned with 
restriction sites in the basic vector PUC 19 (2686) 
(New England Biolabs), were kind gift from Jan 
Cornelis, DKFZ, Heidelberg. 
 
4.1.7 Equipments 
 
Binocular microscope    Leitz (Wetzlar) 
Centrifuge biofuge 15R    Heraeus (Hanau) 
Confocal laser scan microscope   Leica Lasertech (Heidelberg) 
Confocal Leica SP-5     Leica (Mannheim) 
Desk centrifuge 5415 C    Eppendorf (Hamburg) 
Light Cycler PCR     Roche (Manheim) 
Petridishes      Greiner (USA) 
Phase contrast microscope    Zeiss (Heidelburg) 
Rotors for ultracentrifuge    Bechmann (Munich) 
Ultracentrifuge L5-50    Bechmann (Munich) 
Ultrasonic sonicator UW-70    Bendelin Electro (Berlin) 
24 well dishes      Nunc Inc. (USA) 
 
4.1.8 Kits and Extras 
 
DNA ladder marker     Promega (France) 
Hyper film MP (X-Ray films)   Amersham Biosciences (Freiburg) 
Molecular weight marker (Rainbow marker) Amersham Biosciences (Freiburg) 
Western lightning chemiluminescence Reagent Perkin Elmer (Rodgau) 
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4.1.9 Buffers and Solutions 
  
 
DMEM media      4500 mg/L glucose 
(ready to use)    GlutaMax 
     Pyruvate 
 
 
 
PBS (pH 7.4)     171 mM  NaCl 
     3.4 mM   KCl 
                                     10 mM    Na2HPO4 
     1.9 mM   KH2PO4  
 
 
 
PBS-MK                                           500 ml   1X PBS 
                                     500 µl    1 M-MgCl2 
                                        500 µl     2.5 M-KCl 
                                     Do not autoclave, only sterilize by sterile filter. 
  
3% PFA          6 g      Paraformaldehyde 
                  150 ml D/W + 3-4 drops of 3 M KOH 
                                     Dissolve PFA at 55°C for 10 min 
      20 ml 10X PBS and make final volume of 200 ml D/W. 
  
Mowiol/DABCO   2.4 g     Mowiol 
              6.0 g     in glycerin, 
             6 ml   Distill water 
                        6 ml   200 mM Tris-buffer pH 8.5        
stored at -20°C. Add 100 mg DABCO in 1 ml mowiol just 
before the use. 
  
 
 10X Transfer buffer  30 g     Tris 
          144 g   Glycine 
     15%     Methanol 
     Add 1000 ml of distill water and make the pH 8.5 
 
 
10X Transport buffer  200 mM    Hepes (pH 7.3) 
     20 mM      Magnesium acetate 
     100 mM    Potassium acetate 
     50 mM      Sodium acetate 
     10 mM      EGTA 
     Add 1 M DTT just before the use. 
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50X TAE buffer (pH 7.8)   242 g      Tris-base 
      57.1 g     Acetic acid 
          0.5 M      EDTA (pH 8.0) (100 ml)  
                add distill water to make up the volume 1000 ml. 
 
Agarose sample buffer with SDS (6X)    50% (w/v)      Saccharose 
      0.25% (w/v)   Bromophenol blue 
      6X                  TAE 
                                                                       1.2% (w/v)     SDS 
 
PAGE running buffer (20X)             97.6 g    MES  
                 60.6 g    Tris Base 
                 10 g       SDS 
                   3 g       EDTA 
 
PAGE sample buffer (4X)                             4 g          Glycerol 
                                                                         0.682 g    Tris Base 
        0.666 g    Tris HCl 
         0.8 g        LDS 
        0.006 g    EDTA 
                                                   0.75 ml    1% Serva blue G250 
        0.25 ml    1% Phenol Red 
        add 10 ml of H2O. 
 
2x Proteinase K-buffer               200 mM   Tris-HCl (pH 7,5) 
               25 mM     EDTA (pH 8,0) 
                                                                          300 mM   NaCl 
               2%          SDS 
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4.2 Methods 
 
4.2.1 Cell Culture 
 
NBK-324 (New Born Kidney) and HeLa cells (Human Cervical Carcinoma) cell lines were 
maintained in DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 5% Fetal calf 
serum (FCS) and grown at 37°C in 5% CO2.  Huh-7 (Human Hepatoma) cells and EYFP lamin B 
receptor NRK cells were maintained in same above mentioned medium but were supplemented 
with 10% FCS. 
 
4.2.2 Virus preparation and Virus purification 
 
Virus stock was prepared by infection (H-1 virus) of NBK cells with 0.1 PFU of virus per cell and 
incubated at 37°C for 2.5 days. After freezing and thawing for 5 times, the cells were harvested at 
10,500 rpm for 15 min at 4°C. Again 5 times freezing and thawing cycles of the supernatant was 
repeated and aliquots were stored at -20°C. Cell lysates were further purified with iodoxinal 
gradient, which was formed by underlying and displacing the less dense cell lysate with iodoxinal, 
prepared using 60% (w/v) sterile solution of optiprep 10 ml of the crude virus extracts were 
transferred into quick-seal ultra-clear centrifuge tubes (Beckmann, Munich) using a spinal needle. 
This step performed to avoid air bubbles, which would interfere with subsequent filling and sealing 
of the tube. Then 7.5 ml of 15% iodoxinal and 1 M NaCl in PBS-MK buffer (1X Phosphate Buffer 
Saline, 1 mM MgCl2 and 2.5 mM KCl), 2.5 ml of 25% iodoxinal in PBS-MK buffer containing 
phenol red (2.5 µl  of a 0.5% stock solution/ml of iodoxinal solution), 2 ml of 40% iodoxinal in 
PBS-MK buffer, and finally, 2 ml of 60% iodoxinal in PBS-MK containing phenol red  (0.01 
µg/ml) were added in this order. Tubes were sealed and centrifuged by using rotor TST 41.14 at 
36,000 rpm for 4.5 h at 10°C. The purpose of the phenol red was to distinguish the alternating 
density steps. The purified virus was collected from the visible clear 40% phase. Empty capsids 
were collected from the 25% phase and cell debris collected from 15% phase. 
 
4.2.3 Localization of capsids 
  
NBK and HeLa cells (1 x 103 cells) were grown on collagenised cover slips in DMEM medium 
which was complimented with 5% FCS and incubated overnight at 37°C.  Removed the old media 
and FCS free DMEM media (500 µl) was added to the cells and incubated for 10 min at 37°C. 
Cells were infected with different concentrations of H-1 virus and timepoints, which were 
mentioned in each experiment. According to the experiment requirement, cells were treated with 
different inhibitors cycloheximide (50 µg/ml), hygromycin B (300 µg/ml), H89 (10 µm), 
roscovitine (50 µm) and ZVAD-fmk (50 µm) for overnight at 37°C. In another experiment, cells 
were treated with cycloheximide (50 µg/ml) in the presence of H-1 virus for 10 h at 37°C. Cells 
were washed two times carefully with FCS free DMEM media and incubate at 37°C for 30 min 
later H89, roscovitine and ZVAD-fmk inhibitors were added in the DMEM medium supplemented 
with 5% FCS for overnight at 37°C. Cells were washed two times with 500 µl of  1x PBS and fixed 
with 400 µl of 3% paraformaldehyde (PFA) at 4°C for 2 h. Later indirect immunostaining and 
confocal analysis were performed. 
 
4.2.4 pH treated capsids  
 
After growing HeLa cells on collagenised coverslips, acidified the H-1 capsids by treating with pH 
5.2 (potassium acetate buffer) for 10 min at 37°C and followed by neutralisation with 0.5 M Tris 
(1.5 µl). Cells were infected with pH treated and untreated H-1 capsids for overnight at 37°C. Two 
times cells  were washed with 1x PBS (500 µl) and fixed with 3% PFA. 
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4.2.5 Indirect immunofluorescence 
 
After fixation, cells were washed three times with 1x PBS (500 µl) at RT before each well was 
filled with 500 µl 0.1% Triton X-100. The dish incubated at room temperature for 10 min in order 
to permeabilize the cell membranes. After that, the wells were washed three times with 1x PBS 
(500 µl). In the primary antibody mixture, mAb 414 (mouse) was diluted in 1:200 in antibody 
solution (1x PBS, 5% BSA, 5% goat serum), whereas the anti-capsid (rabbit) antibody was diluted 
1:100. For each coverslip, 20 µl antibody mixture was spotted on parafilm in a humid box. The 
coverslips were placed with their cell side on the drop of antibody mixture. The humidified box 
was incubated at 37°C. After 1.5 h, the down side of the coverslips (where cells were attached) 
were rinsed with 100 µl 1x PBS before replaced in the 24 well dishes. The 24 well dishes was 
washed three times with 500 µl of 1x PBS. For secondary antibody reaction, a goat Texas Red- 
labelled anti-mouse antibody and goat FITC labelled anti- rabbit antibody were diluted (1:100) in 
antibody solution. In few experiments, texas red-labelled anti-mouse antibody was replaced by 
goat Cy-5 labelled anti-mouse antibody dilution (1:100) or donkey alexa 594 labelled anti-mouse 
antibodies (1:200), Alexa 488 anti-rabbit (1:200) and propidium iodide (chromosomal stain 
1:1000) were added. This antibody mixture was spotted on parafilm in the humidified box 
followed by transfer of the cover slips as described before. The box was incubated at 37°C for 45 
minutes, the cover slips were rinsed, replaced and washed as described. Drops of DABCO-Moviol 
were spotted on microscopical glass slides and the cover slips placed on them. The glass slides 
were kept overnight in the darkness at room temperature. 
 
4.2.6 Confocal Laser Scanning microscopy 
 
The cells were analysed using a 63X or 40X an apochromat objective by a LEICA DM IRBE. For 
the confocal analysis, the cells were scanned by laser power of 30% a signal of 85 % and a pinhole 
size of 1.0 with two folds magnification. Eight pictures were merged. For the representation of 
FITC, the FITC filter setting was used, for depicting texas red, the TRITC filter were used. The z 
position in all pictures was adjusted to the equatorial level of the cell. The pictures were arranged 
by using the Adobe-Photoshop software program version (8.0.1) on Microsoft Windows platform.  
 
4.2.7 Co-immune precipitation 
 
20 µl of dynabeads were taken for each sample and washed two times with 0.1% of BSA in 1x 
PBS (1 ml). Dynabeads coated with anti-VP1 (10 µl) and mAb 414 antibodies (10 µl), rotate on 
rotating wheel at 1000 rpm at 4°C for overnight. Dynabeads were washed four times with 0.1% 
BSA in 1x PBS (1 ml), resuspended in 150 µl of washing buffer and incubated the beads for 1 h at 
RT and 3 h at 4°C. Rest protocol defined separately. Later Anti-VP1 or mAb 414 coated dynabeads 
were added to the samples and reaction was followed by incubating for O/N at 4°C at 1000 rpm. 
Samples were washed three times with washing buffer (0.1% BSA in 1x PBS (1 ml)), one time 
with 0.1% NP-40 in PBS followed by three times with washing buffer. Finally, pellet was spinned 
down at 4°C, for 10 min at 8200 rpm. Supernatant was removed and the pellet was dissolved in 15 
µl of 1X SDS loading buffer followed by SDS PAGE and western blot. 
 
4.2.7.1 Co-immune precipitation of nups by progeny H-1 and vice-versa 
 
HeLa cells were grown overnight at 37°C. Cells infected by full and empty H-1 capsids for 48 h at 
37°C. Later HeLa cells treated with full and empty capsids, thereafter cells were washed with PBS 
and removed the cells (1x1010 cells) carefully with rubber police. Cell pellet was obtained at 1200 
g for 15 min at 4°C. Pellet was collected and resuspended in 200 µl of PBS and sonified for 15 s at 
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least five times. Final concentration of 0.1% Triton 100X and Protease A were added and 
incubated for 30 min at 37°C.  
 
4.2.7.2 Co-immune precipitation of importin α and anti capsid antibody 
 
Dynabead coating and washing procedure was same as mentioned before. For sample preparation, 
untreated and pH treated H-1 virus was used (pH treatment: 4.6, 5.2 and 6.0 for 10 min at 37°C and 
neutralized with 0.5 M Tris (1.5 µl)). In all samples, importin α (50 ng) and importin β (90 ng) was 
added and incubated for 2 h at RT. Later, dynabeads were mixed with coated VP1 antibody to the 
samples for overnight at 4°C. Rest procedure was same as described in 4.2.7 paragraph. 
 
4.2.8 SDS gel electrophoresis 
 
For proteins, SDS-PAGE was performed according to ready to use gels (4-12% bis-tris gel and 4-
8% Tris-acetate-gel from Invitrogen and Anamed gels (Aplelex). Each sample was dissolved in 15 
µl of 1X SDS loading buffer (Invitrogen) and 1.5 µl of DTT (1M). Samples were heated at 95°C 
for 10 min before loading. The electrophoresis assembly was connected with power supply; a 
voltage of 8 V/cm was applied to the gel. Later, the voltage was increased to 15 V/cm and the gel 
was run until the bromophenol blue dye reaches to the bottom of the resolving gel. 
 
4.2.9 Western blot 
 
4.2.9.1 Western blot (I) 
 
Firstly, activate the PVDF (poly vinylidene fluoride, VWR International, Frankfurt main) 
membrane with methanol for 2 min followed by 2 min with distill water treatment and then 10 min 
incubation with 1X transfer buffer at RT. Proteins were blotted on to the membrane using a wet 
blot chamber from Invitrogen (40mA volts at RT for overnight). Membrane was blocked with 5% 
fat free skim milk in 1x PBS for 1h at RT and followed by incubation for 3 h at RT with primary 
antibodies (anti-capsid, anti-mAb 414 and anti-importin α (1:1000). Membrane was washed three 
times for 10 min with washing buffer (0.5% skim milk and 0.1% tween 20 in PBS) at RT. 
Membrane was incubated with corresponding secondary antibodies (peroxidase anti-rabbit 
(1:5000) / mouse antibody (1:3000)) for 1 h. Membrane was washed three times for 10 min with 
washing buffer and finally, membrane was washed with one time with 1x PBS for 15 min. 
Antigen-antibody immunoreactive reaction was visualized with ECL system (Enhanced 
chemiluminescence system from Perkin Elmer, Rodgau) according to the company instructions. 
 
4.2.9.2 Western blot (II) 
 
Activation of PVDF membrane and running conditions were same as described above. Membrane 
was blocked with 5% skim milk and 0.2% tween 20 in PBS for 1 h at RT followed by primary 
antibody (TAT 1, specific to tubulin) was diluted 1:50 in PBS + 0.2% tween 20 + 0.5 M NaCl + 
0.02% NaN3 at 4°C for overnight.  Membrane was washed three times with 1 M NaCl. Membrane 
was incubated with the corresponding secondary peroxidase anti-mouse antibody with 5% skim 
milk and 0.2% tween 20 in PBS for 1 h at RT. After secondary antibody treatment, washing was 
done with 0.2% Tween 20 in PBS at least four times. Later membrane was visualized for antigen-
antibody complex as described before. 
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4.2.10 Agarose gel electrophoresis 
 
DNA was separated by agarose gel electrophoresis. 1 % agarose in 1x TAE buffer was placed in 
the microwave till the agarose was completely dissolved, allowed to cool slowly, mixed and 
poured into a taped gel tray. Thereafter, the 13 well combs were inserted and the gel allowed 
solidifying. Afterwards, the comb was removed, DNA was loaded along with loading buffer. The 
DNA was electrophoretically separated at a voltage of 75 V. After proper separation, gel was 
placed in 0.5 µl of ethidium bromide (1 mg/ml stock solution) solution for 20 min.  Ethidium 
bromide was a fluorescent dye that intercalates between bases of nucleic acids and allows very 
convenient detection of DNA fragments. Ethidium bromide intercalates DNA and this complex 
becomes fluorescent viewed under UV-light (260 nm wave lengths, UV-25, MarcoVue, Hoefer, 
Germany).  Photographs were taken with a gel camera (RS-1, Kaiser, Clara Vision) by using Gel 
smart V 7.3 software program. To determine the size of the DNA present in the fragment of 
interest, a DNA ladder marker (Promega, Mannheim, Germany) of similar size and known 
concentration was applied and the amount of DNA present in the band of interest estimated by 
comparing it to appropriate marker. 
 
4.2.11 S7 Nuclease digestion of Parvovirus H-1 
 
Parvovirus H-1 was digested with S7 Nuclease at 2 U/µl in the presence of 5 mM CaCl2 for 3 h at 
37°C. S7 nuclease digests both single stand as well as double strand of DNA.  The digestion 
process was stopped by adding supplements of 6 mM EGTA and released the protected viral DNA 
by digestion with proteinase K out of the H-1 capsid.   
 
4.2.12 Gradient passed pH treated capsids 
 
Capsids were treated with pH 4.6 (potassium acetate buffer) for 10 min at 37°C and neutralised by 
0.5 M Tris (1.5 µl) and pH untreated capsids were used as control. Iodoxinal gradient were ran as 
described before at 36,000 rpm for 4.5 h at 10°C (SW 41 Beckmann). Fractions were collected and 
aliquoted 500 µl per vial. All fractions were treated with proteinase K.  
 
4.2.13 Proteinase K digestion 
 
Viral DNA was digested with proteinase K (Roche, Mannheim) to release the viral capsids.  For 
the proteinase K digestion, 1 sample volume of proteinase K in 2X proteinase K buffer was mixed. 
Digestion of the viral DNA and proteinase K mixture was performed by incubating at 65°C for 
overnight. After the digestion process, Phenol-chloroform extraction carried out in order to elute 
the protein contained in the solution. 
 
4.2.14 Phenol-chloroform-extraction 
 
The proteinase K digested samples were transferred with a volume of phenol, vortex for a min and 
centrigued for 10 min by the table centrifuge (5415 Eppendorf) at 14,000 rpm.  In this manner, 
debris denatured and collected itself in the organic phase, while the nuclei acids remain in the 
liquid phase. The upper liquid phase transported into a new eppendorf tube. After the 
centrifugation if, an interphase appeared that contains a mixture of proteins and nuclei acids, this 
had to transfer together with the phenol (1time of sample volume), vortexed and follow the same 
centrifugation process as described above.   
 
The resulting upper phase was taken out and added with a pipette to the first DNA phase.  The step 
was repeated until no more interphase seen.  To remove the rest of the phenol in the DNA phase, a 
32 
volume of chloroform was transferred, vortexed for a min and centrifuged for 10 min at 14,000 
rpm in the table centrifuge. The upper water phase was transported into a new Eppendorf reaction 
tube.  The last step was repeated to develop the interphase. Subsequently the precipitation of the 
nucleic acids obtained through ethanol precipitation. 96% ethanol added to 2.5 sample volume of 
the hydrophilic DNA-containing supernatant and vortexed. The mixture freezed at least for 20 min 
at -70°C. Then centrifugation was performed for 15 min at 4°C and 15,000 rpm. After the 
centrifugation, the obtained supernatant discarded and the DNA pellet dried at RT to remove the 
additional ethanol. The purified nucleic acids further used for PCR. 
 
4.2.15 Determination of Parvovirus H-1 DNA with Real-Time-PCR 
 
All samples applied for PCR reaction must digested with proteinase K digestion, extraction with 
phenol-chloroform and concentration of DNA with ethanol in the presence of tRNA (50 ng) co- 
precipitation with nucleic acids. After purification, nucleic acids resuspended in H2O and directly 
used for the PCR. 10 µl of the sample volume was used for the PCR. H-1 plasmid was used to 
create the standard curve. The H-1 plasmid concentration was quantified with UV-
spectrophotometer Du-70 (Bechmann, Munich, Germany). The plasmids (~1,65 x 1011 copies/µl ds 
DNA) were diluted in H2O. Standard serial dilutions were generated using 1.5 dilution steps for a 
concentration of 5x107 till 1.6 x103 single stranded DNA genome. In Light Cycler, the reaction was 
performed in a glass capillary tube with a volume of 20 µl.  10 µl of template free water was used 
as a negative control. Before the capillaries loaded with the standard curve and the examining 
samples, 10 µl of master mix, necessary primers, probes and enzymes were added.   
 
Following list of the primers were used for the detection of Parvovirus H-1 with Real-Time-PCR 
(Besselsen.DG, et al, 1995) 
 
H-1 3479f: 5´ – CTA GCA ACT CTG CTG AAG GAA CTC – 3´ 
The 5´ and 3´ end of the primers from 24 nucleotides corresponds to the positions (5´- 3´) 3479-
3502 in H-1 parovirus genome. 
 
 H-1 3732r: 5´ – TAG TGA TGC TGT TGC TGT ATC TGA TG – 3´ 
 
The 5´ and 3´ end of the primers from 26 nucleotides corresponds the positions (5´- 3´) 3732-3707 
in H-1 parovirus genome. 
 
The designed primers amplified 254 bp fragments from the 5176 bp of the parvovirus H-1 genome. 
Following sequence of the H-1 genome was selected in this work for the hybridization probes.   
 
H-1 probe 3´FL 5´ – ACT TAC TCA CAC ATG GCA AAC CAA CAG A – 3´ - Fluorescein 
 
The 5´ and 3´ end of the hybridization probe corresponds to the positions (5´- 3´) 3642-3669 in H-1 
parvovirus genome 
 
H-1 probe 5´LC 5´ - LC Red640 – ACT TGG CAT GCC TCC AAG GAA TAA CTG A – 3´ 
 
The 5´ and 3´ end of the hybridization probe corresponds to the positions (5´- 3´) 3671-3698 in H-1 
parvovirus genome 
 
All the preparations were performed on ice to avoid the degradation of hybridization probes. Since 
the probes are photosensitive, all probes were kept in the dark during preparations. 
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The master mix consists of 20 µl volume including following reagents: 
 
   1 µl primer H-1 3479f [10 pmol/µl] 
   1 µl primer H-1 3732r [10 pmol/µl] 
  0,5 µl  H-1 probe 3´FL [8 pmol/µl] 
  0,5 µl  H-1 probe 5´LC [8 pmol/µl] 
  1,6 µl  MgCl2 [25 mM] 
  3,4 µl  H2O 
   2 µl LC-FastStart Reaction Mix (Roche diagnostics, Mannheim), contains Taq polymerase 
enzyme. 
 
Master Mix was prepared with the above described reagents, mixed well and distributed to Light-
Cycler capillaries tubes with a volume of 10 µl. Then after, 10 µl of the sample added. Filled 
capillaries were subjected for a short centrifugation with a speed of 1000 rpm in the table 
centrifuge and carefully placed in the Light-Cycler carrousel. PCR-software program used to run 
the machine with the following conditions. 
 
Denaturing: 1 cycle Temperature Incubation period 
 95°C 10 min 
Increase of temparature 20°C/sec  
  
Amplification: 45 cycles Temperature Incubation period 2. temperature 
Denaturation 95°C 10 sec  
Annealing 62°C 8 sec 53°C 
(Decrease of temperature from 1°C for a cycle till reached the 2.temparature) 
Elongation 72°C 10 sec  
Increase in temperature  20°C/sec   
 
Cooling: 1 cycle Temperature Incubation period 
 40°C 30 sec 
Increase in temperature 20°C/sec  
 
Real-Time-PCR conditions for the Light Cycler were established in this work for the Parvovirus H-
1. After denaturing step at 95°C for a period a 10 min, that was necessary for the activation of the 
relative ducks "almost start Taq" Polymerase. 
 
The PCR was carried out as a "touch down PCR".  In the first amplification cycle, the annealing 
temperature was set to the goal temperature of 62°C.  In every amplification cycle, annealing 
temperature was sunken 1°C until it reaches the second goal temperature at 53°C. 
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In the PCR program, the sample amount and the standard dilutions of known concentrations were 
stored. After completing the PCR cycles, the samples were evaluated.  The measurement canal was 
placed on "Ch 2/1“that measures the light of the wave lengths 640 nm and 530 nm. Through 
blocking the basic line ("Noise volume"), genome concentrations of the samples were calculated in 
different intensities of the fluorescence.   
 
4.2.16 Permeabilized and non-permeabilized HeLa cells treated with H-1 virus 
 
HeLa cells were grown on collagenised coverslips with 5% FCS containing DMEM media for 
overnight at 37°C. Media was removed and cells were washed three times with FCS free media. In 
permeabilzed cells, permeabilization buffer (DMEM media without FCS + digitonin (20 mg/ml) 
1:500, propidium iodide 1:1000) were added for 5 min at 37°C. Cells were washed two times with 
1X transport buffer at RT. H-1 virus was added to the required samples for 30 min at 37°C 
followed by the two times washing with 1X transport buffer. In another set, restained the cells with 
propidium iodide (1:1000) in transport buffer for 5 min at 37°C .Wash the cells two times with 1X 
transport buffer. In non-permeabilized cells, H-1 virus was added in required samples for different 
time points (15 and 30 min) at 37°C. Cells were washed and staining was performed by propidium 
iodide (1:1000) in 1X transport buffer for 5 min at RT. In both cases, cells were mounted with one 
or two drop of DABCO/moviol as described before. Results were determined by phase contrast 
microscopy. 
 
4.2.17 Phase contrast microscopy 
 
Samples were examined by phase contrast microscope (Zeiss, Heidelberg), by using 63X phase-3, 
an apochromat objective with immersion oil was dripped on each of cover slips. 25-50% laser 
intensity used. Pictures were taken by using Micromax camera and captured by Metamorph 
software program. 
 
4.2.18 Live cell microscopy 
 
HeLa cells (1 x 1010 cells) were grown on collagenised petridishes (Falcon, Heidelberg, Germany) 
at 37°C for overnight. Cells were washed two times with FCS free DMEM media at RT, followed 
by the permeabilization (permeabilization buffer: FCS free media, digitonin (20 mg/ml) 1:500 and 
propidium iodide (1 mg/ml) 1:1000) for 5 min at 37°C (prewarmed the permeabilization buffer at 
37°C). Chromatin was stained with propidium iodide. Then after, 2 times washed with 2 ml of 1X 
transport buffer. After permeabilization, 1X transport buffer (100 µl) was added as a negative 
control. Release of chromatin was initiated by addition of H-1 (1.6 x108 capsids) in transport buffer 
(100 µl). Mock purified virus from non H-1 infected cell line (NBK) was purified as same as given 
in section 4.2.2. Cells were pre-incubated with hexokinase (1 U/ml)/glucose (7 mM) of final 
concentration for 10 min at 37°C. In control samples, hexokinase/glucose treatment was not given. 
To see the effect of lamin B receptor, instead of HeLa cells EYFP lamin B expressed cell line was 
used. In negative control, 1X tranport buffer was added. To know the involvment of NS1 protein, 
H-1 virus was pre-incubated with NS1 antibody (10 µl) at 4°C for overnight. In enzymatic 
experiment, in required samples (transport buffer/H-1 virus) was added in the petridish at RT and 
37°C. (pictures were taken for every 5 min till 60 min for RT samples and  for every 2 to 5 min till 
30 min). Apoptotic and mitotic cells were observed by pre-incubation with H-89 (10 µm), 
roscovitin (50 µM) and ZVAD-fmk (50 µM) inhibitors for 2 h at 37°C. These inhibitors were 
present through out the experiment later H-1 (1.6 x108 capsids) were added. In WGA experiment, 
(first low concentrations of WGA were used but did not show any effect to used high 
concentrations) cells were treated with 1mg/ml WGA (lectin from Triticum vulgaris). WGA was 
present through out the experiment. In PLA2 experiment, after permeabilization PLA2 molecules 
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(1.6 x108 PLA2 molecules, Bovine pancreas) were added. To see the effect of NPC on NEBD, cells 
were permeabilized and pre-incubated with phosphorylated HBV capsids (1.2 µg) in the presence 
of cytosol RRL (rabbit reticulysate 21 mg/ml) for 15 min at 37°C. Cells were washed carefully 
with 2 ml of 1X transport buffer and, H-1 was added. In control samples, instead of P-rHBV 
capsids 1X transport buffer was added and incubated for 15 min at 37°C. Pictures were taken by 
confocal microscopy (pinhole size 1.0, 40 X objectives) for every 2 to 5 min. 
 
4.2.19 Confocal analysis and quantification of nuclear fluorescence 
 
A drop of immersion oil was dripped on each of cover slips/petridishes. The cover slips/ 
petridishes were put on the microscope (Confocal Leica SP-5). The cells were analysed using a 
63X (aperture size 1.4) or 40X (aperture size 1.25) an apochromat objective by a HCX PLAPO CS. 
For the confocal analysis the cells were scanned by laser power of 20% a signal of 85% and a 
pinhole size of 1.0, zoom size of 1.5 and all antibodies setting were given below. Pictures were 
taken by LAS AF (Leica Application System Advanced Fluorescence) software program. The z 
position in all pictures was adjusted to the equatorial level of the nuclei. The pictures were 
arranged by using the Adobe-Photoshop software program. Image J software program was used for 
the quantification of the stained nuclei and graphs were prepared in excel data sheets. 
 
Antibody Laser Excitation (nm) Emission (nm) 
Alexa 488 Ar 488 499 520 
Alexa 594 He Ne 543 580 618 
Cy-5 He Ne 633 650 670 
EYFP Ar 514 514 527 
FITC Ar 488 495 519 
Propidium iodide Ar 514 538 617 
Texas-red He Ne 543 595 616 
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5. Results 
 
  5.1 Localisation of H-1 capsids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Most studies on parvoviruses were performed using MVM and CPV. H-1 was choosen as it allows 
investigations without safety precautions incontrast to the before mentioned ones. Despite of its 
ability to infect basically all cell lines but not showing any diseases, is related to H-1 infection. For 
allowing to draw parallels between H-1 and other autonomous parvoviruses we first investigated 
the infection process by monitering the viral capsid using microscopy. 
 
Indirect immunofluorescence analysis was performed with two different cell lines NBK (newborn 
kidney human) which are lytic to H-1 and non-lytic HeLa (cervical cancer cell line, Helenus 
lactinus). These two cell lines were used to localize H-1 viral capsids after infection. Uninfected 
NBK and HeLa cells did not show any capsid fluorescence (figure 1) but the rim-like NPC stain 
(red). Over night infection of the both cell lines with H-1 (100 genome-containing capsids/cell) 
showed a capsid fluorescence (green) indicating specificity of capsid detection and the 
Figure 1: Localization of H-1 parvovirus capsids after overnight infection in NBK (figure 1A) and 
HeLa (figure 1B) cells by confocal laser scanning microscopy after immune staining. Capsid (green) and 
NPC (red). Bar 10 µm. 
Figure.1B. Immunostaining of HeLa cells infected by H-1 
NBK
NBK+ H1 
Capsid NPC Merge 
Figure.1A. Immunostaining of NBK cells infected by H-1 
HeLa + H-1 
HeLa 
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susceptibility of both cell lines. Localization of the capsids was exclusively intranuclear with no 
detectable transport intermediates within the cytoplasm. This finding might indicate a very rapid 
transport through the cytoplasm into the nucleus. Instead, the amount of incoming capsids may not 
be sufficient to cause a visible signal but the strong intranuclear stain is derived from capsid 
multiplication after successful infection. For differentiation dose and time dependent infection 
experiments on HeLa cells were performed. 
 
5.2 Time and dose dependent process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HeLa cells were infected with a low and a high MOI of H-1 (ratio 100:10,000 capsids). Cells were 
fixed after 30 min to visualize incoming virus and after over night incubation, thought to allow the 
synthesis of progeny capsids. No capsids were observed in the HeLa cells that were infected with 
low dose of H-1 after 30 min (figure 2A) but upon infection with 100 times higher dose (figure 
2C). This finding indicates that at low doses of H-1 the signal remained below the detection limit. 
In high dose infection, the capsids stayed cytoplasmic. 
 
However, after over night incubation after low dose infection a strong intranuclear capsid signal 
was achieved (figure 2B), indicating capsid amplification. It must be thus concluded that 
intranuclear capsids represent progeny capsids. 
 
5.3 Effect of mRNA translocation inhibitors on nuclear capsids 
 
For confirmation, two different inhibitors blocking protein synthesis at different steps were used. 
First NBK cells were infected in the presence of hygromycin. This inhibitor blocks protein 
synthesis by disrupting translocation and promoting mistranslation of the ribosome. The results 
were confirmed by cycloheximide which interferes with the peptidyl transferase activity of the 60S 
ribosome, thus blocking translational elongation. 
 
 
 
Figure 2: Localization of H-1 capsids at different time points after infection (HeLa), (A) no binding 
(green) only NPC stain (red) after 30 min infection at low dose, (B) intra-nuclear capsids (green) NPC (red) 
after overnight infection. (C) binding (green) NPC (red) after 30 min infection at high doses. Bar 10 µm. 
      (A)                  (B)          (C)
30 min infection 
       Virus Ratio:           100 :     10,000
30 min 
infection 
overnight 
infection 
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Uninfected (NBK cells)  
H1 binding (2 h) at RT 
H1 binding (2 h) + 2 h 
infection at 37°C+ 
hygromycin 
  Capsid NPC      Merge 
H1 binding (2 h) + O/N 
infection at 37°C  
H1 binding (2 h) +             
O/N infection at 37°C            
+ hygromycin 
 
H1 binding (2 h) + O/N 
infection at 37°C 
H1 binding (2 h) + O/N 
infection at 37°C + 
cycloheximide 
H1 binding (2 h) at RT              
+ hygromycin  
 
 
 
H1 binding (2 h) at RT              
+ 2 h infection at 37°C 
Figure 3A: Influence of mRNA translocation inhibitor on the generation of nuclear capsids (NBK), 
binding of capsid at RT (green), after 2 h and overnight post infection at 37°C intra-nuclear capsid 
observed, binding and intra-nuclear capsids formation was blocked by adding the hygromycin (250
µg/ml) and cycloheximide (50 µg/ml), this experiment shows that intra-nuclear capsids are progeny 
capsids not the incoming virus. Bar 10 µm.  
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Figure 3B: Influence of translational elongation inhibitor on the generation of nuclear capsids 
(HeLa), overview picture showed the quantification. Bar 5 µm. Negative control no capsid stain. 
Overnight H-1 post infection showed intra-nuclear capsid and cycloheximide (50 µg/ml) treated cells. Bar 
10 µm. 
Capsid NPC Merge 
Uninfected (HeLa cells) 
H-1 binding + O/N  
infection at 37°C 
H-1 binding + O/N infection 
at 37°C+ Cycloheximide 
Uninfected (HeLa cells) 
H-1 binding + O/N infection         
at 37°C   
 
H-1 binding + O/N 
infection at 37°C+ 
Cycloheximide 
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Infection was performed by adding the 150 capsids/cell together with inhibitor for 2 h at RT 
followed by incubation for 2 h or O/N at 37°C. Incubations at RT are known to allow receptor 
binding of the virus but active transport processes as endocytosis does not take place as it was 
shown in canine parvovirus (CPV) and feline parvovirus (FPV) (Hueffer.K, et al, 2003).  
 
After 2 h at RT faint capsid signals were obtained in the presence and absence of the inhibitors 
(figure 3A), indicating that the inhibitors did not alter the binding activity of H-1. Further 
incubation at 37°C for 2 h showed a strong signal of intranuclear capsids in some cells of the 
untreated control but no intranuclear capsids in hygromycin treated cells (figure 3A). Consistently, 
an extended incubation at 37°C over night showed intranuclear capsids only in the untreated cells. 
Noteworthy, capsid and NPC stain overlapped intranuclear. Taken together, hygromycin B inhibits 
the intranuclear capsid formation, but did not interfere with the H-1 binding and uptake. In the 
absence of hygromycin B, rapid generation of nuclear capsids formed which supports the idea that 
intranuclear capsids are progeny capsids (figure 3A). Same observation shown incase of 
cycloheximide treated cells (figure 3A). 
 
For excluding a cell line-dependent phenomenon, HeLa cells were infected in the presence of 
cycloheximide. Consistent with the infection of NBK cells, cycloheximide prevented intranuclear 
capsid formation even after over night incubation (figure 3B). As depicted in the magnification,  
same overlap of intranuclear capsid and NPC stain was observed. 
 
5.4 To exclude the cross-talk of antibodies and overlapping of NPC and capsid stain 
 
 
 
                                  
 
 
            
        
 
 
 
 
 
 
 
 
 
 
 
 
The overlap of capsid and NPC stain could be derived from (i) a co-localization of capsids with 
proteins of the NPC that are recognized by the anti-NPC antibody (FXFG containing nups e.g 
nup62, 358 and 153) (DavisLI and Blobel.G, 1986, Wu.J, et al, 1995, Shah.S, et al, 1998), (ii) a 
cross reactivity of the primary antibodies or (iii) a “bleed through” of the strong capsid 
fluorescence into the filter used for detection of the texas red-labelled secondary antibody that 
indicates the NPC (595- 616 nm).  
 
Figure 4: Analysing the overlapping stain of NPC and progeny H-1 capsids. (A) Capsids are 
depicted in green the NPCs in blue, in (B) vice-versa. This analysis showed the co-localization of 
the capsid staining. Bar 10 µm. 
A 
B 
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To exclude the latter phenomenon, which is a technical artefact, a different secondary antibody for 
detection of the NPC was used. Cy5 was chosen as the emitted light is detected by a filter of 652-
775 nm. At this long wave length FITC fluorescence (495-519 nm) can practically not be detected.  
In another experiment the second antibodies were exchanged, meaning that the capsids were 
visualized by Cy5 and the NPC by FITC. Figure 4 depicts that both detections after over night 
infection showed a significant co-stain, indicating that either the primary antibodies cross-reacted 
or that in fact progeny H-1 and NPC proteins were associated within the nucleus. It must be 
considered however that in the previous experiments no co-stain was observed for intracytosolic 
capsids, making cross-reactivity unlikely. Consistently, an interaction of the capsids with one or 
more antibody-reactive proteins of the NPC so called nucleoporins must be assumed. 
 
5.5 Interaction of nucleoporins with H-1 capsids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For obtaining physical evidence for a capsid nucleoporins interaction (nup 358, 214, 153 and 62 
complex). Lysates from HeLa cells, infected with empty and full capsids for 24 h was used. As 
negative control non-infected cells were used. After SDS PAGE and blotting the nucleoporin-
bound capsids were detected with anti-VP1 antibodies. In the vice versa reaction, nucleoporins 
bound to capsids were visualized using the mAb 414 (after co-precipitation with the anti-capsid 
antibody). 
 
Figure 5 depicts that both precipitations were specific in that no signal was obtained when  the 
lysate of uninfected cells were subjected to the co-precipitation. Using the lysate from cells 
infected with full H-1, the nucleoporins Nup 358, 218 and 153 were co-precipitated. No signal was 
obtained using lysates from HeLa cells infected with empty capsids (figure 5A).  
 
Consistently, mAb 414 co-precipitated capsids out of the full H-1 infected lysate as indicated by 
the 88 kDa band of VP1 and the 66 kDa band of VP2 (figure 5B). The missing band of VP3 that is 
a cleavage product of VP1 upon viral entry implies that these bands are derived from progeny 
capsid proteins. This assumption is in accordance with the missing capsid bands in the infection 
experiment to which empty capsids were added. In this sample no multiplication of capsids 
proteins took place.  
nup 358 
  1      2      3 
nup 153 
  1       2        3
nup 214 
88 kDa (VP1) 
66 kDa (VP2) 
(A) (B) 
Figure 5: (A) Co-immune precipitation of nups by progeny H-1. Nucleoporins Nup 358, 218 and 153 
were co-precipitated with the full capsids. (B) Co-immune precipitation of H-1 by nups. Full H-1 
infected lysate as indicated by the 88 kDa band of VP1 and the 66 kDa band of VP2. Lane 1: HeLa cells 
(uninfected), Lane 2: HeLa cells + empty capsid, Lane 3: HeLa cells + full capsids.         
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5.6 Effect of pH on H-1 capsids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parvoviruses enter the cell by endocytosis, requiring acidification (Bartlett.JS, et al, 2000, Basak.S 
and Turner.H, 1992, Parker.JS and Parrish.CR, 2000). At low pH the hidden N terminal domain of 
VP1 (VP1 unique part, VP1up) become exposed (Suikkanen.S, 2003). To analyse whether capsid 
(proteins) and genome dissociated upon acidification, we performed an experiment in which H-1 
pH 4.6 treated and untreated capsids were subjected to gradient centrifugation analysis. Before 
giving the pH treatment H-1 was digested with S7 nuclease that was inhibited after the degradation 
reaction. After centrifugation fractions were analyse for VP1, density and viral DNA. In both 
preparations viral DNA was found in the fast migrating, heavy fractions (density 1.16). This effect 
was slightly move pronounced in the pH treated capsids. pH treated and untreated capsids were not 
showing difference in density between the capsid proteins in both cases the density peak is at 1.24 
H-1                                                        H-1 pH4.6 treated with Tris  
1  2  3  4   5  6  7  8   9  10  11 12 13 14  15 1  2  3  4   5  6  7  8   9  10  11 12 13 14  15 
220  kDa 
 
97.4 kDa 
66    kDa 
 
46    kDa 
 
 
21.5 kDa 
 
14.3 kDa 
Figure 6A: Effect of acidification on parvoviral entry.  pH 4.6 treated and untreated capsids after 
neutralization tris (0.5 M).  Passed with iodoxinal gradient (15%, 25%, 40% and 60%), centrifugation 
done for 2.5 h at 10°C. Aliquoted the different fractions. SDS PAGE (Bis Tris gel 4-12%) and western 
blot was performed and developed with anti-capsid antibody. 
Lanes        Samples 
 
1 Marker 
2 X 
3 15% fraction 1
4 15% fraction 2
5 15% fraction 3
6 25% fraction 1
7 25% fraction 2
8 25% fraction 3
9 40% fraction 1
10 40% fraction 2
11 40% fraction 3
12 60% fraction 1
13 60% fraction 2
14 60% fraction 3
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Lanes        Samples 
 
1 X 
2 15% fraction 1 
3 15% fraction 2 
4 15% fraction 3 
5 25% fraction 1 
6 25% fraction 2 
7 25% fraction 3 
8 40% fraction 1 
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10 40% fraction 3 
11 60% fraction 1 
12 60% fraction 2 
13 60% fraction 3 
14 X 
15 Marker 
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(figure 6B). Modification of viral capsids may thus allow the exposure of NLS which is needed for 
nuclear targeting and transport of viral particles, but did not show any sign of disintegration of the 
capsids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.7 Role of importin α on pH treated capsids 
 
To analyse whether pH treatment indeed leads to NLS exposure as it was described to occur upon 
endocytotic acidification. Co-immune precipitations of the capsid were performed after addition of 
importin α/β. H-1 was treated with different pH (4.6, 5.2, and 6.0) for 10 min at 37°C then 
neutralised with tris base. Importin α and β were added in equimolar ratio to the pH treated capsids 
and incubated for 2 h at RT. Importin β was added as it stabilizes the NLS importin α binding in 
some cases (hepatitis B capsids, unpublished). After SDS PAGE, blotting and immune reactions 
the blot was developed with importin α and anti-capsid antibodies (figure 7). 
 
By using an importin α antibody only those capsids which were treated with pH 4.6 revealed a co- 
precipitation being in accordance with the idea that acidification is required for importin α that 
initiates nuclear entry.  
 
Figure 6B: Structural changes occurred due to pH treatment. pH 4.6 treated and untreated capsids 
after neutralization tris (0.5 M) after iodoxinal gradient centrifugation. No significant difference between 
the density of the capsid proteins were visible. Blue lines: PCR average (in triplates), red lines: density 
gradient, green lines: capsid protein. 
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5.8 Detection of pH treated H-1 capsids by immunofluorescence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pH:      4.6       5.2   6.0 
(A) 
(B) 
Figure 7: Co-immune-precipitation with anti- importin α and anti capsid antibody. H-1 was treated 
with different pH (4.6, 5.2, and 6.0) for 10 min at 37°C, neutralised with tris (0.5 M). pH treated capsids 
were incubated with importin α (50 ng) and β (90 ng). (A) Blot was developed with anti-importin α 
antibody, pH 4.6 treated capsids showing the band which represents that acidification is required and 
low pH treated capsids interact with importin α for nuclear entry. (B) Blot was developed with anti-
capsid antibody, showed the same pattern of bands in all pH treated capsids. 
Figure 8: Effect of pH treated H-1 capsids on HeLa cells. (A) HeLa uninfected, NPC (red) no capsid 
(green) stain was observed. (B) H-1 infection at 37°C, showing the progeny capsids (C) pH (5.2) treated 
H-1 capsid showed reduced % of infection. Bar 10 µm. 
HeLa uninfected 
H1 infection 
H1 infection + pH 5.2 
Capsid         NPC Merge 
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        Sample  Red (NPC stain) Green (capsid stain) % of infected cells 
HeLa (negative control)            666                 0                     0 % 
H-1 (positive control)            596               238              39.9 % 
H-1 + pH 5.2            624                16                2.5 % 
 
 
Acidification is frequently the cause why viruses- or subviral structures- entering the cell are 
different from the progeny viruses that are appointed to leave the cells. Thus the effect of 
acidification on infectivity was determined. Without treatment wt H-1 infected ~39.9% of HeLa 
cells as observed by indirect immunofluorescence, taking the progeny intranuclear capsids as 
determinant. In contrast pH 5.2 treated H-1 which was neutralised showed only 2.5% of infection 
rate.  In negative control no infected cells were observed (figure 8). 
 
In accordance with the distribution of endosomes/lysosomes in cells the appearence of the green 
capsid fluoresences was interpreted as binding of capsids or capsids that extend to the endosomal 
pathway. Thus we assumed that the pH treatment still allowed the exposure of the ligand domain 
on capsids surface but no nuclear import. From this experiment it has to be left open whether this 
block occurred upon escape from the endosome or at later stages of infection. 
 
5.9 Kinetics of H-1 at different time course 
 
To elucidate further possibilities of parvoviral nuclear import, high dose infections of HeLa cells 
(1000 capsids/cell) were performed allowing to follow the fate of the intracellular capsids by 
indirect immunofluorescence. Cells were infected for different time points (10, 30, 60, 120, 240 
min and overnight). Figure 9A depicts that with increasing time more capsids (green) entered the 
cells and accumulated outside the nuclear envelope (blue) in the perinuclear region. Detailed views 
on the cells however, showed that in 11% of infected cells a local disruption of nuclear envelope 
occurred after over night (ON) incubation (figure 9B). The discontinuity was combined with a 
leakage of chromatin (red) out of the nucleus. Leakage of chromatin was restricted to those sites 
where H-1 capsids (green) accumulate and started over night post infection. 
 
To verify whether this phenomenon is restricted just to the HeLa cells or a general phenomenon 
another cell line (HuH-7; human hepatocytes) was analyzed. In fact the local nuclear envelope 
disruption was also observed in 8.5% of the infected cells (figure 9C). 
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Figure 9A: Local disruption upon infection of HeLa cells with ~1000 H-1/cell. Analysis by confocal 
laser scanning microscopy at different time points given above. H-1 and NPC were stained by indirect 
immunofluorescence; the chromatin stained by propidium iodide. The colors above the panels show the 
corresponding structures. Bar 10 µm. 
HeLa uninfected
10 min infection
30 min infection 
60 min infection 
120 min infection 
240 min infection 
ON infection
  Capsid             NPC          Chromatin       Merge           Merge            Merge 
Figure 9B: Magnifying view of leakiness of nuclear envelope. Bar 10 µm 
Capsid                                  NPC                               Chromatin 
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5.10 Live cell microscopy with mock purified virus 
 
Previous studies on permeabilized cells showed that nuclei were hardly detectable after subjecting 
H-1 (Kann.M, unpublished). According to the nuclear disintegration observed before the loss of 
nuclei might be explained by the ability of H-1 to disintegrate them. 
 
In order to verify this assumption, in vitro experiments were performed on permeabilized HeLa 
cells using live cell microscopy. In these assays, cells were permeabilized with digitonin, which 
solubilises only cholesterol-containing membranes as the plasma membrane, leaving e.g. ER and 
nuclear membrane unchanged. 
 
Permeabilization was combined with chromatin stain using propidium iodide. Unincorporated 
stain, digitonin and soluble cytosolic proteins were removed upon the subsequent washing step. 
After addition of 1.6 x108 H-1 (300 capsids/cell) in buffer, nuclear disintegration was monitored by 
the loss of propidium iodide using confocal microscopy at defined time points. 
 
In a first experiment, the effect of H-1 was compared with buffer and a mock-purified virus at 
37°C. In the latter assay, a lysate was used from uninfected NBK cells being purified as it was 
done for purification of H-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0 min          2 min         4 min         6 min         8 min       13 min        18 min      23 min        28 min
Figure 10A: Live cell confocal microscopy of the nuclear entry of mock treated cells and H-1 virus
after permeabilization of HeLa cells. Nuclei were stained with propidium iodide. Pictures were taken at 0, 
2, 4, 6, 8, 13, 18, 23 and 28 min. (A) In negative control (transport buffer) was added, no change in 
chromatin stain (B) mock purified virus (NBK cells), no change in chromatin stain (C) H-1 virus showed 
linear degradation of NE which represents that H-1 is causing degradation. Bar 10 µm. 
A 
B 
C 
         Capsid              NPC             Chromatin           Merge           Merge                Merge 
Figure 9C: NEBD upon infection of HuH-7 cells with ~1000 H-1/cell. Analyses by confocal laser scan 
microscopy at different time points given above. H-1 (green) and NPC (red) were stained by indirect 
immunofluorescence; the chromatin stained by propidium iodide (red). Bar 10 µm. 
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Figure 10B: Quantification data of mock and H-1 treated HeLa cells. Pictures were taken at 0, 2, 4, 6, 8, 
13, 18, 23 and 28 min. Quantification was perofrmed for each cell. Intensity of propidium iodide was 
calculated at each time point. (1) Black lines: transport buffer (negative control), light blue lines: mock 
purified virus. (2) black lines: transport buffer, red lines: H-1 virus. 
 
Figure 10A showed that in both buffer and mock exposed nuclei chromatin stain remained 
unchanged (half life not determinable). Addition of H-1 result a loss of chromatin as indicated by 
the PI stain (figure 10A) showing a loss of chromatin to 50% within 4-8 min (later on referred to 
be the “half-life”). The quantification was monitored in 13 different experiments and is depicted in 
figure 10B. 
 
To verify whether this phenomenon was specific for H-1 or can be generally transferred to other 
parvoviruses we analyzed the degradation potential of the autonomous canine parvovirus (CPV) 
and the non-autonomous adeno-associated parvovirus (AAV).  
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5.11 Live cell microscopy of different parvoviruses  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As indicated in figures 11A, B and C, CPV caused a similar loss of propidium iodide stain as H-1. 
The reaction was somewhat slower showing the half-life of 8 min while H-1 exhibited a half-life 
of 6 min. It must be considered however that the half-life observed for H-1 mediated NEBD varied 
between the experiments so that a significant difference can not be concluded. In contrast, AAV 
did not affect the nuclei.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure11B: Quantification of the loss of chromatin stain induced by autonomous and non-
autonomous parvoviruses. Black lines: transport buffer, red lines: H-1 virus, green lines: canine 
parvovirus. 
A
B 
C 
 
D 
0 min      2 min        4 min       6 min        8 min       13 min      18 min     23 min       28 min 
Figure 11A: Check out the nuclei degradation process on other parvoviruses. HeLa cells were 
permeabilized with digitonin. Washed and pre-incubated with transport buffer for 10 min at 37°C (A, B, C, 
D). Later cells were treated with different parvoviruses. Nuclei were stained with propidium iodide 
asdescribed earlier. (A) Transport buffer, no change in chromatin staining. (B) On H-1 treatment,
degradation of chromatin (C) CPV treatment, same kind of degradation shown as in H-1 (D) AAV treated 
cells, no change in chromatin stain. Bar 5 µm. 
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Figure11C: Quantification of the loss of chromatin stain induced by autonomous and non-
autonomous parvoviruses. Black lines: transport buffer, red lines: H-1 virus, pink lines: adeno-associated 
virus. 
 
5.12 Release of substrate after H-1 induction 
                                                                                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The loss of chromatin stain indicated a disruption of the nuclear envelope. Accordingly not only 
chromatin, but also other substrates should be released. For prove of this hypothesis Alexa647-
 
 
Figure 12A: H-1 induced release of substrates from digitonin-permeabilized cells. After 
permeabilization Alexa647-BSA conjugates with M9 domains were imported (blue). Chromatin was 
stained with propidium iodide. After washing (a) In negative control only transport buffer was added.
(b) The release was initiated by addition of H-1 The fluorophores were monitored by confocal laser 
scan microscopy. Bar 5 µm. 
(Alexa M9) 
(a) 
(Propidium iodide) 
(Alexa M9) 
 
(Propidium iodide) 
(b) 
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BSA conjugated with a M9 domain, having a MW of ~97 kDa, was imported into the nuclei of 
digitonin-permeabilized cells. The 38-residue M9 domain of hnRNPA1 is sufficient to confer 
import into the nucleus. The import reaction is facilitated by the nuclear import receptor transportin 
that is a member of the importin ß superfamiliy. Thus the import reaction was performed in the 
presence of cytosol following the protocol of nuclear import analysis in digitonin-permeabilized 
cells. After washing steps to remove the cytosol and non-imported conjugate a propidium iodide 
stain was performed. Following subsequent washing, H-1 was added. 
 
Figure 12A depicts an overlapping signal of imported M9-BSA (blue) and chromatin (red). In 
buffer-treated cells both intranuclear substances remained stable while addition of H-1 released 
M9-BSA with a half-life of 5.8 min (mean value of H-1 treated cells) followed by chromatin loss at 
6.3 min (mean of all H-1 treated cells). These data indicate that once the nuclear envelope was 
showing small pores allowing the conjugate to leave the nuclei, the disintegration process 
proceeded rapidly leading to pores large enough to release even the chromatin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12B: Quantification of figure 12A. Black lines: negative control, Alexa647-BSA M9 conjugate. 
Pink lines:  Negative control, chromatin determined by propidium iodide. Dark blue lines: H-1, Alexa647-
BSA M9 conjugate. Red lines: H-1, chromatin determined by propidium iodide. 
 
5.13 Analysis of nuclear degradation by EYFP lamin B receptor NRK cell line 
 
Two integral proteins such as lamin B receptor (LBR) and lamin associated polypetide2 (LAP2) 
are present on inner nuclear membrane (Ellenberg.J, 1997). LBR is a chromatin-binding protein 
(Belmont.AS, et al, 1993, Broers.JL, et al, 1999), its isotypes are associated with the nuclear 
envelope (NE) and becomes disintegrated during mitosis (Ellenberg.J and Lippincott-Schwartz.J, 
1999). In the following analysis, we used live-cell imaging of green fluorescent protein (EYFP)-
tagged proteins in conjunction with LBR an INM protein to monitor the effect of H-1 virus. 
 
Chromatin (red) and lamin B receptor staining (green) remained unchanged for the 28 min 
observation period in transport buffer treated nuclei (negative control). In contrast, loss of lamin B 
receptor and chromatin fluorescence was significantly detected when H-1 was added. Release of 
lamin B receptor was slightly faster than the escape of chromatin showing half-lives of 6 min 
versus 8 min being consistent with the assumption that the Lamin B is degraded first before the 
escape of the chromatin (figure 13A/B).  
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Figure 13B: Degradation of LBR upon H-1 treatment. Transport buffer (negative control): Black 
lines: lamin B receptor, green lines: propidium iodide, H-1 virus: red lines: lamin B receptor, blue lines: 
propidium iodide.  
 
Propidium-
iodide 
Lamin-B 
receptor 
Merge 
(a) 
Propidium-
iodide 
Figure 13A: Kinetic of nuclear envelope breakdown monitored by the fluorescence of the lamin B 
receptor and chromatin EYFP expressed NRK cells were permeabilized with digitonin. Lamin B 
receptor was visualized in green and chromatin in red. (a) No change in lamin B receptor and chromatin 
fluorescence was occurred when the nuclei were treated with buffer, (b) After H-1 treatment lamin B 
degraded first with a half life of 6 min while the half life of chromatin was 8 min. Bar 5 µm. 
(b) 
Lamin-B 
receptor 
Merge 
0 min     2min        4 min       6 min       8 min       13 min      18 min     23 min       28 min 
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5.14 Analysis by wide field microscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After permeabilization (in the presence of propidium iodide), cells were treated with either 
transport buffer (negative control) or with H-1 virus for 30 min at 37°C  in parallel assays (figure 
14A). Cells were washed and one set was restained with propidium iodide solution (figure 14A 
(b)). This was performed to exclude whether the observed loss of fluoresence was infact caused by 
chromatin release or by a dissociation of the propidium iodide. Further analysis was done with 
wide field microscopy (WFM) because this microscope depicts the whole nuclei from top to 
bottom at one plane.   
 
The infection experiments suggested that nuclear disintegration is a local process restricted to the 
site where H-1 has accumulated. In permeabilized cells however H-1 has access to the outside of 
the nuclei on all sites at the same time. An exception is the bottom of the nuclei where they are 
attached to the surface of the glass cover slip.  
 
These results showed that, after H-1 treatment most of the propidium iodide staining was lost but 
some fluorescence was still present. 
 
Quantitative ananlysis in figure 14B depicts that the concentration of propidium iodide remained 
the same in stained and restained nuclei. This latter finding shows that the loss of propidium iodide 
stain, observed in the experiments before was in fact caused by a release of chromatin and not by a 
destain of it. In the H-1 treated cells the concentration of the stain stayed identical but the area was 
significantly reduced implying that some chromosomes were lost. The remaining chromatin was 
not condensed upon H-1 treatment. 
 
Transport buffer           H-1      Transport buffer                            H-1 
 
    Stained (a)          Restained (b) 
Figure 14A: Treatment of H-1 upon permeabilized HeLa cells. Pictures were taken from phase 
contrast microscopy. (a) Stained HeLa cells with buffer showing total chromatin stain but in H-1 treated 
cells some chromatin stain got lost. (b) In re-stained HeLa cells with buffer showing no difference and 
same phenomenon observed in H-1 treated cells. 
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Figure 14B: Quantification analysis of HeLa cells upon H-1 treatment. (a) Propidium iodide 
concentration stayed same in stained and restained nuclei (intenstiy of stain calculated in single cell). (b) 
Total chromatin fluoresence was calculated in each cell which showed that loss of propidium iodide staining  
caused by a release of chormatin but not because of de-staining. (c) Size of stained area remained same in 
buffer (stained and restained) as well as in H-1 treated cells (stained and restained) only the area reduced. 
Bar represents the average. 
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Wide field microscopy  
 
 
Confocal microscopy  
 
Figure 14C: Schematic diagram of H-1 treated cells by using different microscopes. (A) After 
permeabilization (a) in buffer (control) chromatin stayed attached. (b) After H-1 treatment chromatin leaked  
(A) 
a) b) 
(B) 
(C) 
a) b) 
a) b) 
(D) 
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out and few chromatin remained attached to the suface of the cell. (B) The adherence of the attached 
chromatin may be explained by the estabilished interaction between chromatin (red) and Nup 153 (green) 
via lamin associated protein (LAP, blue) (C) In wide field microscopy (WFM), pictures represents all levels 
of the nucleus (a) in the negative control (buffer) thus a wide fluoresence occurs while (b) in H-1 treated 
nuclei most of the chromatin had leaked out and only the remaining stain can be depicted. (D) In confocal 
analysis in contrast, only the fluoresence in equatorial section was recorded. (a) buffer treated cells showed  
thus a similar fluoresence  as in WFM while (b) in H-1 treated cells, no chromatin staining was observed. 
 
This assumption can be explained by the attachment of the chromatin with the nuclear envelope 
that stayed attached to the coverslip. Buendia.B and Courvalin.JC, (1997) reported that Lamin 
associated protein 2 (LAP2) – as depicted in figure14C (B) – connects the chromatin with the 
Nup153 that is part of the nuclear basket. The result thus implies that the Lamin was not entirely 
degraded but stayed integer at some parts of the nuclei. 
 
This assumption explains the different outcome of the permeabilization when using different 
microscopes (for schematic presenatation see figure 14C): When confocal laser scan microscopy 
was used, the equatorial level of the cells was depicted while the wide field microscopy shows the 
nuclei in full depth. Remaining chromatin, attached to the bottom of each nucleus, closed to the 
surface of the glass cover slip can be thus detected (figure 14C (C). 
 
According to this assumption phase contrast showed a degradation of nuclear shape upon H-1 
treatment without a total loss of nuclear structure.  
 
 
5.15 Effect of permeabilized YEFP lamin B receptor expressing cells upon H-1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For further support to this hypothesis, remaining EYFP lamin B receptor was recorded in wide 
field microscopy upon H-1 treatment. Figure 15 shows that in fact the area of lamin B receptor 
fluorescence was reduced but remained attached to those areas where phase contrast microscopy 
depicted residuals of the permeabilized cells. 
 
 
(TB) 
(H-1) 
Figure 15: Effect of permeabilized YEFP lamin B receptor expressing cells upon H-1 treatment. 
Pictures were taken by wide field microscopy. (TB) No change observed in staining (red- chromatin stain,
green- lamin B receptor). (H-1) Lamin B receptor stain was reduced but some fluorescence remained 
attached to those areas where phase contrast microscopy depicted residuals of the permeabilized cells. 
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5.16 H-1 treatment of non-permeabilized HeLa cells 
 
If the observed phenomena of the nuclear envelope degradation reflect a physiological effect only 
the nucleus but not the plasma membrane should be affected. For control we thus evaluated the 
effect of H-1 on the plasma membrane of integer cells. As marker for permeabilization propidium 
iodide was used as this stain cannot pass the plasma membrane. 
 
Figure 16A shows faint red signal in all cells irrespectively to the addition of H-1. Most likely 
these signals were derived from autofluorescence. One strong staining in the presence of H-1 but 
the irregular shape most likely indicates H-1-independent cell fragments, which is consistant by its 
appearance in phase contrast. 
 
                                                                                                                                                              
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
         
       
 
 
 
 
 
 
5.17 Effect of NS1 protein on nuclear disruption 
 
In order to evaluate the viral component that mediates the nuclear degradation and chromosomal 
escape we analysed the impact of different capsids and NS1. CPV and H-1 show high homology 
regarding all proteins. VP1 and VP2 both forming the capsid are identical in 51% and 52% of the 
amino acids respectively. The protein NS1 that is exposed on capsid surface on only genome-
containing capsids is 73% identical. In contrast H-1 and AAV show identities of 30%, 29% for 
VP1 and 2 and only of 37% in a domain of 265 residues of the NS1 (termed Rep in AAV). 
 
The extremely high homology of NS1 between CPV and H-1 might be a plausible reason why both 
parvoviruses disintegrated the nuclei while AAV showing a more limited Rep-homology does not. 
Thus first the role of NS1 was evaluated for nuclear disintegration. As NS1 is only present on 
DNA containing capsids (full capsids) but not in empty capsids both capsid types were compared 
for their potential to cause nuclear envelope breakdown (NEBD). 
 
5 min without H-1 
30 min without H-1 
30 min H-1 
    Phase contrast                  Propidium iodide 
(B) 
(A) 
Figure 16: Effect of plasma membrane upon H-1 treatment. Pictures were taken with phase contrast 
microscopy. (A) Non-permeabilized HeLa cells 5 and 30 min without treated with H-1. 30 min treated with 
H-1 no change has been showed to plasma membrane. (B) Permeabilized HeLa cells. 
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Figure 17B: Chromatin-release by H-1 under various conditions. The graphs show the quantification of 
experiments as in figure 18A. For every cell fluorescence’s were standardized to the one at 0 min, which 
was set. Effect of NS1 on nuclear disruption. Black lines: negative controls with buffer. Red lines: H-1 in 
buffer. Blue lines: anti-NS1 pre-incubated H-1. Green lines: Empty H-1 (not harbouring NS1). 
 
As depicted before, cells were treated with buffer (negative control) no loss of chromatin staining 
in between 0 to 30 min recorded in figure 17A. In contrast 1.6 x 108 full H-1 capsids caused a 
significant loss of chromatin staining (half-life 4 min) (figure 17A/B). Same amounts of empty 
capsids however, failed to induce nuclear disintegration. 
 
Despite of the homologies structural differences on the capsid surface cannot be excluded to be 
responsible for the degradation. For differentiation between a capsid or an NS1 mediated process, 
full capsids were pre-incubated with an excess of anti-NS1 antibodies. This pre-incubation in fact 
  
A
Figure 17A: Effect of NS1 protein on nuclear degradation. Live cell microscopy was performed by 
confocal laser scan on permeabilized HeLa cells. Chromatin was stained with propidium iodide. (A) No 
change in chromatin after treated with buffer. (B) On H-1 (full capsid) treatment loss of chromatin. (C) H-
1 was pre-incubated with anti-NS1 antibody showed no change in chromatin. (D) Empty capsids (devoid 
of NS1) were unable to show any degradation. NS1 protein involves in nuclear degradation. Bar 5 µm. 
 
  0 min          2 min     4 min          6 min       8 min       13 min     18 min      23 min      28 min 
B 
C 
D 
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decreased disintegration to a half-life of the propidium iodide fluorescence to 30 min. The 
inhibition however was incomplete may be because of an incomplete saturation of NS1 by the 
antibody.  
 
5.18 Kinetics of nuclear degradation at different temperatures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The nuclear envelope break down (NEBD) observed for H-1 and CPV was should be an 
enzymatically triggered process. For further confirmation the effect of temperature was evaluated.  
H-1 capsids were subjected to HeLa cells at different temperatures (room temperature and 37°C) 
and the obtained results were compared with transport buffer treated cells (negative control). As 
shown by confocal live cell imaging, no effect was observed in the buffer treated cells (negative 
control) at room temperature and 37°C at all time points figure 18A. In contrast, loss of chromatin 
was observed with a half life of 30 min at room temperature (20°C) in H-1 (1.6 x 108 capsids) 
treated cells figure 18A (a). Cells exposed to H-1 (1.6 x 108 capsids) at 37°C, loss of chromatin 
was observed much faster (6 min) figure 18 A (b).  
 
   0min            5min             10min           15min           30min        45min          60min       
H-1 at Room temperature (a) 
A
B
H-1 at 37°C (b) 
  0min         2min          4min        6min          8min      13min        18min       23min     28min 
A 
B
Figure 18A: Kinetics of propidium iodide loss upon H-1 treatment at room temperature and 37°C 
on permeabilized HeLa cells. (a) H-1 at RT: (A) No change in chromatin after treating with buffer. (B) 
Loss of chromatin seen after 30 min upon H-1 treatment. (b) H-1 at 37°C: (A) No chromatin loss seen 
after buffer treatment. (B) Degradation of chromatin showed after 6 min of H-1 treatment at 37°C which 
represents that nuclear disruption is temperature dependent process. Bar 5 µm. 
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Figure 18B: Kinetics of nuclear disruption at room temperature versus 37°C. Black lines: negative 
control with buffer at room temperature. Red lines: H-1 in buffer at room temperature. Green lines: negative 
control with buffer at 37°C. Blue lines: H-1 in buffer at 37°C. 
 
5.19 Role of ATP/ or GTP in NEBD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An enzmatically driven NEBD should require energy generally derived from hydrolysis of 
triphosphates. Thus the requirement of ATP and/or GTP was investigated. This experiment was 
performed because although the permeabilized cells were washed  some nucleotides were assumed 
to be present. In fact some protein kinases are known to be activated by only nano molar amount of 
A
B 
C 
 
D 
0 min      2 min        4 min       6 min        8 min       13 min      18 min     23 min       28 min 
Figure 19A: Role of ATP/ or GTP in nuclear degradation. HeLa cells were permeabilized with digitonin. 
Washed  the cells and pre-incubated in transport buffer for 10 min at 37°C (A and B). cells were pre-
incubated with (C and D) hexokinase and glucose (ATP/GTP depletion). Nuclei were stained with 
propidium iodide (A) Transport buffer showed no change is chromatin staining. (B) On H-1 treatment 
degradation of chromatin staining were observed. (C) Pre-treated cells with hexokinase and glucose then 
transport buffer was added, no change in chromatin stain were shown. (D) Pre-treated cells with hexokinase 
and glucose then H-1 virus was added, no change in chromatin stain has been observed (blocked the nuclear 
degradation process) which shows that energy is required for nuclear degradation. Bar 5 µm. 
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ATP. Permeabilized cells were treated with hexokinase/glucose prior to the addition of H-1. 
Hexokinase was of Saccharomyces cerevisiae  origin that utilizes both ATP and GTP. The 
hexokinase/glucose system is well established for energy depletion in various nuclear import 
assays (Schwoebel.ED, et al, 2002, Nakamura.N and Wada.Y, 2000). 
 
As depicted in figure 19A/B a gradual degradation of nuclei staining was observed upon H-1 virus 
treatment in permeabilized HeLa cells, but not after treatment with the ATP/GTP depleting system.  
 
Taken together, all these observations suggest that NEBD is an enzymatic catalysed pathway 
requiring ATP and/or GTP. To explore the underlying enzymatic mechanism in more detail, we 
asked 1. Are apoptotic and mitotic key enzymes are involved? 2. Are cytosolic proteins involved in 
this process? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19B:  Role of ATP/GTP in the loss of chromatin staining (quantification). Black lines: transport 
buffer (TB). Red lines: H-1 virus. Green lines: TB (hexokinase/glucose). Blue lines: H-1 (hexokinase/ 
glucose) 
 
5.20 Role of apoptosis and mitosis in NEBD 
 
Physiologically NEBD occurs during mitosis and apoptosis. The executing enzymes during these 
processes are casapase-3, cyclin-dependent kinase-2 (cdk-2) and protein kinase C (PKC). As 
described before, the lamina is a dynamic structure whose disassembly during mitosis is regulated 
primarily by phosphorylation of the lamins at conserved serine residues flanking the α-helical rod 
domain (Heald.R, and McKeon.F, 1990, Stuurman.N, et al, 1998). During apoptosis, one step in 
the irreversible disassembly of the nuclear lamina involves hyperphosphorylation of lamin B 
proteins by protein kinase C (PKC) (Brodie.C, and Blumberg.PM, 2003). Distinct from mitotic 
lamin phosphorylation, major PKC phosphorylation sites on lamin proteins have been mapped to 
serine residues located in close proximity to the nuclear localization signal in the C-terminal tail 
domain (Hocevar.BA, et al, 1993). Other cellular lamin kinases include mitogen-associated protein 
kinases and cyclic AMP-dependent protein kinase. During apoptosis, PKC has been shown to 
translocate to the nuclear membrane and to phosphorylate lamin B at the C-terminal domain, 
thereby inducing apoptotic lamina disassembly (Brodie.C, and Blumberg.PM, 2003, Buendia.B, et 
al, 1999).   
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Figure 20B: Effect of mitotic and apoptotic inhibitors on H-1 treated cells. Black lines: transport buffer 
(negative control). Red lines: H-1 virus. Green lines: H-1 with H89 inhibitor. Blue lines: H-1 with 
roscovitine. Pink lines:  H-1 with ZVAD-fmk. 
 
To elucidate the involvement of apoptotic and mitotic enzymes during NEBD upon H-1 treatment, 
live cell inhibitory experiments were performed by using H-1 (1.6 x 108 capsids) as control and in 
the presence inhibitors H89 (PKC), roscovitine (cdk-2) and ZVAD fmk (caspase 3 and caspase 9). 
Results obtained from these experiments suggest that, cells treated with transport buffer sample 
were remained to be unchanged. Intact chromatin was observed in all time points figure 19A (A). 
Loss of chromatin was observed a half life of 8 min in H-1 treated group figure 20A (B). Cells 
treated with a H89 (10 µm) for a period of 45 min, inhibits the phosphorylation of protein kinase C 
A 
B 
C 
D 
E 
  0 min         2 min       4 min       6 min        8 min        13 min     18 min      23 min      28 min
Figure 20A: Effect of mitotic and apoptotic inhibitors on pre-treated HeLa cells (permeabilized) 
later H-1 added. (A) No chromatin loss observed after buffer treatment (negative control). (B) Loss of 
chromatin showed after H-1 treatment. (C) Degradation blocked in those cells which were pre-incubated 
with H-89 inhibitor. (D) Roscovitine inhibitor. (E) Z-VAD-fmk inhibitor which showed 
phosphorylation, cdk2 and caspases are involved in nuclear degradation. Bar 5 µm. 
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activity, did not observe any change towards chromatin staining and it remained to be integer 
figure 20A (C). Cells treated with roscovitine (50 µm) inhibit the cdk-2 activity, did not detect any 
significant changes in chromatin staining figure 20A (D). Cells treated with ZVAD-fmk (50 µm)  
inhibit caspase-3 and caspase-9 activity, were showing same observation as mentioned with H89 
inhibitor figure 20A (E). These results were further supported by quantification data figure 20B. 
Taken together all these observations, we conclude that, apoptotic and mitotic inhibitors block  H-1 
mediated NEBD.  
 
 
5.21 Involvement of cytosolic proteins in live cell microscopy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Physiologically NEBD depends on cytosolic proteins (which ones) that enter the nucleus. Although 
the cells were washed after permeabilization it could not be excluded whether remaining cytosolic 
proteins were involved in H-1 mediated NEBD. In order to analyze the effect on washing the 
proportion of remaining cytosolic proteins was evaluated. As a marker tubulin was selected as the 
microtubules collapse upon permeabilization and washing. Figure 21A/B shows that in fact 98 % 
of the cellular tubulin was removed. As tubulin is fixed at insoluble structures it must be concluded 
that this number underestimates the release of other soluble proteins as e.g. nuclear transport 
receptors. Figure 21C shows that in both samples same amounts of DNA were present indicating 
that the same number of permeabilized cells was analyzed. 
 
5.22 Role of WGA at NEBD process 
 
As indicated by the previous experiments, H-1 need to contact with the outer part of the nuclear 
envelope to induce NEBD. Further full H-1 was determined to interact with proteins of the nuclear 
pore. For closer evaluation the effect of Wheat Germ Agglutinin (WGA) was evaluated. WGA is a 
lectin that binds to N-glycosylated proteins present on cytoplasmic face of the nuclear pore. 
Thereby WGA blocks active nuclear import reactions facilitated by nuclear transport receptors 
(Finlay.DR, et al, 1987). A pore glycoprotein thus appears to be either directly involved in nuclear 
transport or to be placed in such a position that WGA can, by binding to it, obstruct the passage of 
Figure 21: Immunoblotting done with α-tubulin antibody. SDS-PAGE (10-20% Tris glycine gels) and 
western blot performed for samples (A) Supernatant and (B) pellet, lane M is representing a rainbow 
protein marker showing band of 66 kDa. Lane 1 to 6 dilution series (1, 1/4, 1/16, 1/64, 1/256, 1/1024) of 
non-permeabilized HeLa cells showing the band of 50 kDa of α-tubulin. Lane 7 to 12 dilution series of (1, 
1/4, 1/16, 1/64, 1/256, 1/1024) of permeabilized HeLa cells. (C) DNA gel (1% agarose) showed DNA 
ladder marker in lane M , lane 1 is non-permeabilized HeLa cells (pellet) and lane 2 is permeabilized HeLa
cells (pellet). 
C 
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nuclear proteins through the pore. The most likely candidate for the target of WGA binding is the 
62 kDa pore glycoprotein observed by Davis.LI and Blobel.G (1986). 
 
Figure 22A shows that addition of WGA has had poor effect on H-1-mediated NEBD. This 
observation implies that an active nuclear import of H-1 is not required. In fact this idea is in 
accordance with the observation that the permeabilized cells are devoid of significant amounts of 
soluble cytosolic proteins as e.g. the nuclear transport receptors. Quantification showed in figure 
22B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22B:  Quantification of WGA treated cells upon H-1. Evaluation done by student t-test for each 
cell at each time point. Black lines: transport buffer (negative control). Green lines: H-1 in buffer. Red lines: 
H-1 with WGA. 
 
 
 
A
B 
C 
0 min         2 min          4 min          6 min        8 min        13 min        18 min        23 min       28 min 
Figure 22A: Role of WGA at nuclear envelope breakdown upon H-1 treatment on permeabilized 
HeLa cells. Chromatin was stained with propidium iodide. (A) No change in chromatin stain upon 
buffer treatment. (B) Degradation of chromatin stain seen after H-1 treatment. (C) WGA (1mg/ml) 
treated cells upon addition of H-1 showed the degradation of chromatin. This result represents that WGA 
does not have any effect on nuclear degradation. Bar 5 µm. 
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Figure 23B: Role of PLA2 enzyme on HeLa cells. Quantification was performed with student t-test. 
Chromatin determined by propidium iodide. Black lines: transport buffer (negative control). Blue lines: 
PLA2 enzyme in buffer. 
 
Another possible mechanism of how H-1 may have mediated NEBD might be the phospholipase 
A2 activity identified on the N-terminal domain of VP1 in a variety of parvoviruses. This region 
harbours a phospholipase A2 (PLA2) domain (Zadori.Z, 2001) that generates holes in membranes 
but, contradiction to the postulated role in nuclear transport allowing diffusion of small molecules 
of only ~3 kDa (Suikkanen.S, 2003). PLA2 activity however was shown to be essential for release 
of the capsid from the endosomal compartment into the cytosol (Farr.GA, 2005, Suikkanen.S, 
2003, Zadori.Z, 2001). Noteworthy, capsid release is inefficient and the majority of capsids end in 
the lysosomal compartment (Mani.B, 2006). However by unknown reasons the two evaluated 
PLA2 inhibitors (Manoalide and AACOCF3) added caused an immediate nuclear disintegration 
irrespectively to the presence of H-1. For circumventing the problem the direct effect of PLA2 on 
nuclei was evaluated.  
 
Similar kind of live cell microscopy performed as described before instead of H-1 virus PLA2 
enzyme (1.6 x108 molecules) added to the cells to see the effect of PLA2 enzyme on cells. Negative 
control (transfer buffer) remained unaffected (figure 23A) whereas cells treated with PLA2 
enzyme, showed that nuclei stayed integer but cells got swelled up (figure 23A). The cells were 
5.23 Effect of phospholipase A2 (PLA2) on HeLa cells 
A
B 
0 min         2 min          4 min        6 min         8 min         13 min       18 min       23 min       28 min 
Figure 23A: Live cell confocal microscopy done on permeabilized HeLa cells to show the effect 
of PLA2 enzyme. Chromatin is shown in red. (A) No change in chromatin after treated with buffer. 
(B) After PLA2 enzyme treatment cells swelled up due to unknown reason. Bar 10 µm. 
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certainly not only swollen in 2 dimensions but also in altitude. However, we measured the intensity 
based on pictures done with the same pinhole size. So for quantification, we used square root of 
area of each cell which was multiply by intensity of the propidium iodide for each cell to check 
that whether the cells were affected by PLA2 enzyme or not. Plotting the calculated intensities of 
the nuclei (figure 23B) showed that PLA2 enzyme did not cause any chromatin escape. 
 
5.24 Live cell microscopy of phosphorylated HBV capsid 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24B: Nuclear pore complex involved in nuclear envelope breakdown. Pictures were taken at 0, 
2, 4, 6, 8, 13, 18, 23 and 28 min. Quantification was performed for each cell and intensity of propidium 
staining calculated at each time point.  Black lines: transport buffer (negative control), red lines: H-1 virus, 
Green lines: HeLa cells pre-incubated with P-rHBC then treated with H-1 virus. 
 
 
Figure 24A: Nuclear pore complex play a role in nuclear envelope breakdown. (A)  Transport buffer
showed  no loss of chromatin staining. (B) H-1 virus, loss of chromatin staining observed. (C) Cells were 
pre-incubated with phosphorylated r-HBV capsids then H-1 was added, degradation process blocked. 
NPCs play an important role in nuclear envelop break down. Bar 5 µm. 
 
A 
B
C
0 min       2 min       4 min        6 min       8 min        13 min      18 min      23 min      28 min 
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The missing inhibition of NEBD by WGA only exclude that an active nuclear import via transport 
receptors is a prerequisite for NEBD, it does not exclude that the parvoviruses that directly interact 
with the NPC causing this phenomenon. For further analysis if an interaction between H-1 and 
NPC is required for NEBD the pores were blocked with capsids of the hepatitis B virus (HBV). 
 
In E.coli-expressed HBV capsids become imported into the nuclear basket via importin α and ß. 
Within the basket, they are arrested thereby blocking the nuclear pore. Permeabilized cells were 
pre-incubated with phosphorylated HBV capsids in the presence of cytosol before-after washing-
H-1 (1.6 x 108 capsids) was added. As in previous experiments, the propidium iodide fluorescence 
was recorded. Chromatin staining stayed unchanged throughout the 30 min observation period in 
the negative control but disappeared in the H-1-exposed nuclei. Preloading of the NPCs by the 
HBV capsids in contrast blocked NEBD up to 80%, while the half-life of H-1 treated positive 
control was 6 minute (figure 24A/B). These data demonstrate that an H-1 NPC interaction triggers 
NEBD and suggests a direct interaction with nucleoporins as a cause for this phenomenon. 
 
5.25 Role of apoptotic and mitotic markers on H-1 infected HeLa cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Although NEBD was observed in permeabilized cells and upon infection it remained unclear, 
whether the same enzymes are essential in infection. To address this question kinetic infection 
experiments were performed by adding high doses of parvovirus H-1 (1000 capsids/cell) with the 
different inhibitors for the enzymes that execute NEBD. Discontinuous nuclear envelopes were 
analyzed 2, 4 and 8 h post infection. As depicted by confocal microscopy, uninfected HeLa cells 
displayed the integer NPC staining with no capsid staining (2, 4 and 8 h). In contrast, infected 
HeLa cells cause local disruption of the NE and the leakage of chromatin out of the nucleus in 10%  
     Capsid            NPC        Prop. iodide        Merge          Merge           Merge             
HeLa uninfected 
HeLa infected 
H-1 infection   
+ H-89 
H-1 infection                 
+ Roscovitine 
H-1 infection         
+ ZVAD-fmk 
Figure 25A: Kinetic experiment by using different apoptotic inhibitors (2 h). Bar 5 µm. 
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              Capsid             NPC         Prop. iodide       Merge            Merge             Merge 
HeLa uninfected      
H-1 infection 
H-1 infection           
+ H89 
H-1 infection                      
+ Roscovitine 
H-1 infection                      
+ ZVAD-fmk 
Figure 25B: Kinetic experiment by using different apoptotic inhibitors (4 h). Bar 5 µm. 
 
 Capsid              NPC         Prop.iodide        Merge             Merge            Merge 
HeLa uninfected 
H-1 infection 
H-1 infection      
+ H89 
H-1 infection     
+ Roscovitine 
H-1 infection     
+ ZVAD-fmk 
Figure 25C: Kinetic experiment by using different apoptotic inhibitors (8 h). Bar 5 µm. 
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of the cells only in 8 h incubation figure 25C. Leakage was restricted to those cells where H-1 was 
accumulated in the nuclear periphery in 2 and 4 h (figure 25A/B). 
 
When cells were pre-incubated with H89, roscovitine and ZVAD-fmk (which inhibit PKC, cdk-2 
and caspase-3 & 9 activities) no chromosomal leakage was observed, although capsids were 
accumulated at the perinuclear region.  
 
To analyze the effect of the inhibitors on infection the incubation period was extended to over 
night. As described before, cells were treated with H89, roscovitine and ZVAD-fmk inhibitors 
(which inhibit PKC, cdk-2 and caspase-3 & 9 activities). Figure 25D shows that all inhibitors 
suppressed the generation of progeny capsids. Notheworthy H89 treated cells still allowed 
accumulation at the perinuclear region while roscovitine treated cells showed more a dispersed 
cytoplasmic or plasma membrane attached staining. Quantification table showed above (% of H-1 
infected HeLa cells). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            Sample Red (NPC stain)   Green (Capsid stain) % of infected cells 
HeLa (negative control)             595                 0                                 0  % 
H-1  (positive control)             673               210                              32 % 
H-1 + H89 (10 µm)             619                 2                0.4 % 
H-1 + Roscovitine (50 µm)             591                 0                                 0  % 
HeLa uninfected 
HeLa + H-1 infection 
H-1 infection                 
+ H89  
H-1 infection                 
+ Roscovitine 
Figure 25D: Role of apoptotic inhibitors on H-1 infected HeLa cells at over night incubations. 
Capsids are in green and NPC is in red.  Bar 10 µm. 
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5.26 Effect of apoptotic and mitotic inhibitors on synthesis and transport of progeny H-1 
capsid 
 
However, the inhibitors may have interfered not only with the nuclear transport of the H-1 genome 
but with synthesis or nuclear transport of the progeny capsids. To differentiate the experimental 
protocol was modified. Cycloheximide was added during the uptake of H-1 followed by washing 
of the cells to remove the inhibitor. At this time H89, Roscovitin and ZVAD-fmk were added. This 
experimental design was performed to allow first the NEBD-dependent penetration of H-1 into the 
nucleus without allowing synthesis of progeny capsids followed by synthesis of progeny capsids 
from the nuclear H-1 DNA. Accordingly if H89, Roscovitine or ZVAD-fmk interferes with 
synthesis of progeny capsids, no nuclear progeny capsids should be generated. 
 
Figure 26 and Table show that 70% of the cells showed progeny nuclear capsids in the positive 
control. Cycloheximide treatment reduced the number of successfully infected cells to 5.9%. The 
reason for this inhibition was not further evaluated but the block may occur on several levels for 
e.g. the requirement for new receptor synthesis for efficient entry or clathrin synthesis. 
 
Irrespectively, H89 and Roscovitine treatment totally prevented generation of nuclear capsids 
although some cytoplasmic capsids were visible at least in PKC inhibited cells. As the capsid stain 
in cdk-2 inhibited cells was closed to the background in uninfected cells at least a strong reduction 
in capsid protein synthesis must be assumed. 
 
In contrast, cells treated with ZVAD-fmk showed a similar proportion of nuclear capsids then in 
the only cycloheximide treated cells thus indicating that caspase-3 do not interfere with synthesis 
or transport of the progeny capsids. Thus its inhibitory function on infection must be carried by its 
action on preventing NEBD giving an evidence that NEBD is not a side effect but essential for the 
viral life cycle. 
 
 
 
 
 
  
 
 
          Sample Total cells (NPC 
stain)                         
Nuclear capsids 
(green) 
% of cells with nuclear 
capsids 
HeLa (negative control)             1103                0                 0  % 
H-1  (positive control)             1023              720                70 % 
H-1+ cycloheximide             1005               60                5.9 % 
H-1+ cyclo+ H89               682                0                  0 % 
H-1+ cyclo+ Roscovitine              338                0                  0 % 
H-1+ cyclo+ ZVAD- fmk              980                    40                           4 % 
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HeLa uninfected  
HeLa H-1 infection 
H-1 + cycloheximide 
H-1 + cycloheximide                 
+ H89  
H-1+ cycloheximide                     
+ Roscovitine 
H-1+ cycloheximide                     
+ ZVAD-fmk 
Figure 26: Confocal immunofluorescence images of H-1 infected HeLa cells treated with 
cycloheximide, showing capsids (green), NPC (red) by using different mitotic and apoptotic 
inhibitors H89 (PKC), roscovitine (cdk2) and ZVAD-fmk (caspase 3-9). To conclude this PKC and 
cdk-2 are required for nuclear import but not caspases.  Bar 5 µm.  
 
 
 Capsid          NPC                      Merge 
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6. Discussion 
 
The nuclear import of parvoviruses is a controversial topic. So far three different models of 
parvovirus nuclear entry have been proposed basing on NLS exposure or PLA2 and NS1 activity. 
As our data are surprising and controversial, we searched for alternative pathways. 
 
We observed that parvovirus capsids localised within the nucleus after overnight infection being 
inhibited by addition of hygromycin and cycloheximide (figure 3A/B). These findings suggest that 
mRNA translocation and protein synthesis are requirement for the generation of intranuclear 
capsids arguing against a direct entry of the capsids upon entry. Similarly, others showed that these 
inhibitors inhibit the productive infection in HIV (Gatti.PJ, et al, 1998) and coronavirus 
(Sawicki.SG and Sawicki.DL, 1986). In agreement with this assumption, high level infection is 
being clearly above the detection limit of the applied immunofluorescence (IF) did not demonstrate 
the nuclear entry within the first 2 h of post infection. Within such a time, endocytosis and nuclear 
transport should have been occurred as demonstrated for CPV (Vihinen-Ranta.M, et al, 2000) that 
uses the same import strategy. In case of CPV, the nuclear transport of the capsids was slow and 
with sufficient amount found in the nucleus only after 3 to 6 h after infection. Except parvoviruses 
some other viruses also use the endosomal pathway for entry e.g.  Rubella virus, Vaccinia virus 
(Petruzziello.R, et al, 1996 and Townsley.AC, et al, 2006). 
 
In-direct immunofluorescence showed co-staining of parvoviral capsids and proteins of the NPC 
within the nucleus. By using different secondary antibodies for detection of NPC and parvovirus 
capsids showed co-localization was not derived from bleed through of the filter but either by cross-
reaction of the primary antibodies or by an interaction of progeny H-1 and NPC proteins (figure 4). 
Further experiments showed that in fact progeny capsids interact with nucleoporins explicitly with 
nups 358, 214 and 153 that bind to the anti-NPC antibody (figure 5) implying that the capsid can 
interact with the nuclear pore. 
 
Acidification process is crucial for the entry of parvoviruses such as AAV and CPV (Barlett.JS, et 
al, 2000, Basak.S and Turner.H, 1992). These observations were also seen in parvovirus H-1, that 
requires acidification prior to penetration and thereby causes productive infection. Infact density 
gradient analysis of the acidified and untreated capsids did not show any significant difference 
corresponding to the co-immune precipitation of capsid proteins and viral genome (figure 6A/B). 
However, capsid structure was apparently changed as infection capacity was lost. According to the 
literature (Cotmore.SF, et al, 1999) this structural change should further lead to NLS exposure on 
the VP1up concomitantly as demonstrated for CPV. 
 
Importin α should interact with this domain as it plays an essential role in nuclear import of protein 
exhibiting a classical NLS (Lange.A, et al, 2007). Infact these finding could be verified for H-1 in 
that acidification allowed coprecipitation of importin α (figure 7). However, incoming capsids did 
not extend the nucleus thus the effect on pH-driven disassembly was investigated. By iodoxinal 
gradient centrifugation no disintegration was observed as viral DNA and capsids migrated together, 
irrespectively to acid treatment (figure 6B).  
 
As our results were not consistent with the proposed models of parvovirus nuclear import, we 
searched for an alternative nuclear import pathway and observed local disruption of the nuclear 
envelope in 11% HeLa cells (figure 9A). Disruption of the nuclear envelope was occurred only in 
that area where H-1 was accumulated and accompanied by chromatin leakage (figure 9B). Similar 
results were also obtained in Huh-7 cells (8.5%) suggesting that disruption was not cell line 
specific (figure 9C). The leakiness of the nuclear envelope was also observed in poliovirus 
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(Belov.GA, et al, 2004). In addition, our data on permeabilized cells, in which nuclei were hardly 
detectable after subjecting H-1 to the nuclei supports the notion. Furthermore, in vitro experiments 
showed that H-1 was disintegrated with a half-life of 7 min (figure 10A/B). Half-life was defined 
to be a reduction of the chromatin to 50%. This loss was similar in all cells indicating an 
independent stage of the cell cycle in which the cell has been (but true for only those cells with 
nucleus). After 10 to 13 min, the nuclei appeared to be entirely disrupted. This was in agreement 
with the 10 min time span observed by (Lenart.P, et al, 2003) for NEBD upon mitosis in intact 
cells. Further, mock-purified virus did not show any effect on chromatin staining (figure 10A/B). 
Chromatin condensation was an indicator of mitosis observed in all experiments but did not help to 
differentiate between an apoptosis or mitosis like process at the time of permeabilization. Further, 
investigations were performed to obtain the evidence for generalization to other parvoviruses 
showed that CPV showed same kind of loss of chromatin staining as in case of H-1 (figure 11A/B). 
The observations were in accordance to the findings of Cohen.S, et al, (2006) who demonstrated 
that microinjection of MVM into the cytoplasm of Xenopus oocytes caused damage to the nuclear 
envelope (NE). This suggests that the nuclear-import mechanism of MVM involves disruption of 
the NE and import through the resulting breaks. While these data suggest that all parvoviruses 
follow the same strategy, our data on AAV which did not cause any nuclear envelope breakdown 
(NEBD) (figure 11A/C), imply that this phenomenon was particular for the autonomous 
parvoviruses. 
 
Despite of the different amino acid sequences parvoviruses share a common capsid structure and 
more or less similar NS1 protein being attached. However, capsid structure was not only modified 
by acidification upon entry but also differ in empty and full capsids. Additionally, only full capsids 
exhibit the NS1 protein (Cotmore.SF and Tattersall.P, 1989). Although demonstrated to be cleaved 
off upon endocytosis (Cotmore.SF and Tattersall.P, 1989), analysis of the viral components that 
facilitate NEBD, should include NS1. First it has to be considered that not the entire protein is 
removed (Nuesch.JP, et al, 1993). Due to the low ratio of parvovirus particles versus infections 
units (< 200:1) it cannot be excluded that few capsids that represent the infectious ones still inhibit 
the entire NS1. 
 
Our investigations thus included empty and full capsid as well as the necessity of NS1. In fact anti 
NS1 pre-incubation of the virions reduced the half-life of chromatin to ~25 min, six times more 
than in the positive control (figure 17A/B). Empty capsids did not exhibit any observable NEBD 
activity, seemingly supporting that NS1 is the viral partner that causes the degradation. In fact, 
homology search via BLAST showed that H-1 (NS1) and CPV (NS1) showed 73.2% identity in 
671 residues showing the overlapping whereas, H-1(NS1) with AAV (Rep) showed 37.4% identity 
in 265 residues was overlapped. 36.6% similar identity was observed in CPV with AAV showing 
overlapping in 265 residues.  
 
In NEBD, early spindle microtubules caused folds and invaginations in the NE up to 1 h prior to 
NEBD, creating mechanical tension in the nuclear lamina proteins. The first gap in the NE then 
appeared before lamin B depolymerization, at the site of maximal tension, by a tearing mechanism. 
Gap formation relaxed this tension and dramatically accelerated the rate of chromosome 
condensation. These produced holes in NE rapidly expanded over the nuclear surface. At last, NE 
fragments remaining on chromosomes were removed towards the centrosomes, which appeared to 
be a microtubule dependent manner. (Beaudouin.J, et al, 2002).  
 
The time cause in mitosis was shown to be initialized by the formation of pores in the NE followed 
by a rapid condensation of the nuclear membranes allowing that larger macromolecules can escape 
(Lenart.P and Ellenberg.J, 2006). For analysing whether parvovirus-induced NE degradation 
follows the same kinetic we determined the half-life of two other parameters namely the escape of 
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M9-BSA–a 97 kDa conjugate (Kann.M, et al, 1999) that indicates the formation of small pores and 
the lamin B receptor that was inserted into the nuclear membrane upon expression of as EYFP 
fusion protein (Ellenberg.J, et al, 1997). To gain insight into the parvovirus NEBD, experiments 
were performed basing on kinetics. We observed LBR disappearance with a half-life of 6 min, 
chromatin loss 8 min in the same experiment (figure 14A/B) accompanied by 5.8 min of M9-BSA 
and 6.3 min (figure 12A/B) of propidium iodide (chromatin stain). Thus our data suggest loss of 
the LBR receptor fluorescence followed by the escape of the M9-BSA. Having the size of ~97 kDa 
(diameter of at least 7 nm), thus other latter result is in agreement of the natural NEBD upon 
mitosis as corresponding holes were described by Lenart.P and Ellenberg.J (2006) after onset of 
mitosis. 
 
Membrane degradation could have been occurred by the PLA2 activity that is encoded on VP1up 
(Zadori.Z, et al, 2001). As we could not entirely exclude that some parvoviruses expose this 
domain despite of pH treatment, we analysed the impact of PLA2. Such an activity cleaves a 
phospholipids ester bond as demonstrate for the PLA2 of cobra venome PLA2 (Dennis.EA, 1997, 
Dennis.EA, et al, 1981). Thus only small holes should be generated being in accordance with 
findings of (Suikkanen.S, et al, 2003) that observed a permeability of endosomal membranes for 
molecules smaller than 3 kDa. To verify this finding for nuclear membranes, we incubated 
permeabilized nuclei with PLA2 (bovine pancreas). In fact we observed a swelling of the nuclei at 
8 min after subjection, which may indicate formation of small pores in the outer nuclear membrane 
from an osmotic swell. However at no time, even 28 min after onset of the experiment, chromatin 
loss was detected (figure 23A/B). PLA2 of bovine pancreas and the parvoviruses may however 
exhibit other properties so that the swelling could be interpreted as a first stage in NE degradation. 
Subjection of known inhibitors (AACOCF3 and Manoalide) to permeabilized cells, however failed 
as both of them depleted the nuclei instantly after subjection. Nonetheless it must be considered 
that all studied parvoviruses exhibit such an activity including AAV that failed to cause NEBD.  
 
Excluding such a general mechanism as the global membrane degradation, we asked which 
structure on the NE may have triggered NEBD. The microscopic finding showed that parvovirus 
interact with nucleoporins even with a hidden NLS led us to focus on the NPC. 
 
WGA, a lectin has been shown to inhibit the accumulation of nuclear proteins by blocking the 
translocation step of the transport (Adam.EJ and Adam.SA, 1994, Finlay.DR, et al, 1987), 
probably by the interacting by O-gylcosylated nucleoporins (Finlay.DR, et al, 1987). Further WGA 
prevents nuclear apoptosis, suggesting that important mediators of apoptosis were not able to enter 
the nuclear compartment. Our findings from WGA treated cells upon H-1 virus showed similar 
degradation as observed on H-1 treatment (figure 22A/B). Thus, WGA does not affect the 
degradation of the nuclei by H-1. This observation indicates that no transport receptors are required 
in parvovirus NEBD, which is consistent with the absence of these factors in our assays. The 
interpretation however implies that parvovirus directly interacts with the nucleoporins but evidence 
has to be given experimentally. Seemingly failure of WGA to prevent NEBD is in divergence to 
the data of Vihinen-Ranta.M, et al, (2002) obtained after the microinjection of CPV. Keeping in 
mind that nuclear capsids represent imported progeny capsids, the finding may reflect that the 
progeny capsid subunits are imported into the nucleus by the classical import receptor-mediated 
pathway rather than the entering capsids pass the nuclear pore. Consistent with this hypothesis 
Riolobos.L, et al, (2006) showed that a trimeric complex of MVM VP1 and VP2 exhibit a nuclear 
translocation motif responsible for nuclear import of the complex via importins. 
 
Based on the hypothesis that an NPC interaction is needed for NEBD we blocked the pores by pre-
treating the permeabilized cells with an excess of phosphorylated hepatitis B virus capsid (P-HBc) 
(figure 24A/B). P-HBc interacts directly with nup 153 (Schmitz, unpublished) but depend upon 
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importin α and β for translocation into the nuclear basket (Kann.M, et al, 1999) where this 
nucleocapsid is anchored to the NPC. Due to this interaction the capsids become arrested allowing 
accumulation inside the pores. In fact investigation by electron microscopy showed up to seven P-
HBc per NPC (Pante.N and Kann.M, 2002). 
 
This preload of the pores in fact totally inhibited NEBD by H-1 supporting that nucleoporins – 
interaction triggered the reaction. Consistent with this idea nucleoporins (Nup 153, 358) are 
involved in initialisation of mitosis (Macaulay.C, et al, 1995, Salina .D, et al, 2003). Except 
mitosis, nucleoporins also play a central role in apoptosis (Fahrenkrog.B, 2006). The observation 
that the nuclear pores are involved and that these nucleoporins interact with H-1 capsids including 
nup 153 - however allows a further interpretation of inhibition by anti-NS1 antibody. This divalent 
antibody can cause a complex of two times 26 nm H-1 capsids connected a by 10 nm measuring 
antibody (NS1). Such a structure is at the limit size of the NPC which is 39 nm (Pante.N and 
Kann.M, 2002). The complex has thus poor excess to nucleoporins that are not exposed on the 
exterior of the NPC as e.g. nup 153. Consequently this experiment does not exclude that may be 
the structural differences between the empty and full capsids cause their different impact on 
NEBD. 
 
The absence of soluble cytosolic factors in our assays (figure 21) implies the nuclei already contain 
the executing enzymes for NEBD that need to be activated. During apoptosis an activator 
apparently has to be imported through the nuclear pores as the WGA inhibition experiments 
mentioned earlier suggest (Buendia.B, et al, 1999). This implies that the imported activator is a 
“normal” karyophilic cargo that enters the lumen of the nucleus where it diffuses. Parvovirus 
however could not be seen inside the nucleus upon infection even when NEBD was visible. 
Moreover NEBD was a local phenomenon at those sides of the nucleus where the capsids 
accumulated. In agreement with these findings we found that NEBD in the permeabilized cells 
only took place at those parts of the nucleus that were accessible from the cytosolic side to the 
capsids. 
 
Based on these data parvovirus mediated NEBD may thus use the same or a different activation 
pathway than that is described for apoptosis or mitosis. We thus added different apoptotic and 
mitotic inhibitors on HeLa cells which inhibit different enzymatic activity required during mitosis 
and apoptosis. These inhibitors were H89, roscovitine and ZVAD-fmk which inhibits protein 
kinase C (PKC), cyclin dependent 2 (cdk2) and caspase 3-9 activity. Cdk2 drives the G2 phase 
cells into mitosis within 30 minutes (Furuno.N, et al, 1999). Recent studies showed caspase 3 is 
activated immediately before the cells enter mitosis (Hsu.SL, et al, 2006). During apoptosis, 
caspase 3 is actively transported to the nucleus and increase the diffusion through the nuclear 
pores. This increase of the nuclear pores allow the passage to caspase 3 and other molecules which 
could not pass through the nuclear pore of the living cells in and out of the nucleus during 
apoptosis. Treatment of digitonin-permeabilized cells inhibited parvovirus-mediated NEBD 
demonstrating that the physiological degradation pathway was used. Moreover the applied 
inhibitors blocked the leakiness of the nuclear envelope in infection (figure 25) without affecting 
capsid accumulation at perinuclear region. In order to analyse the impact of these findings for 
infection we analysed the effect of inhibitor treatment on the appearance of nuclear progeny 
capsids. An interference with virus uptake was not observed but generation of nuclear capsids was 
totally inhibited. Nonetheless these findings could have been based on an inhibition of synthesis or 
an interference with nuclear import of the capsid subunits. In fact PKC as well as cdk-2 inhibition 
was shown to prevent the synthesis of nuclear capsids. While PKC inhibition apparently just 
interfered with translocation into the nucleus cdk-2 inhibition blocked the synthesis of the progeny 
capsids (figure 26). The latter observation is in accordance with cdk-2 participation in 
complimentary strand elongation (Bashir.T, et al, 2000). The effect of the PKC inhibition can be 
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explained by the unpublished data on MVM where phosphorylation of the VP1- (VP2) complex is 
essential for its nuclear import (Riolobos, unpublished). Nonetheless caspase-3 allowed capsids 
synthesis and nuclear entry leading to the conclusion that its inhibitory function on NEBD upon 
infection and inhibition of successful infection is correlated (figure 26). 
 
Irrespectively to the obtained results on permeabilized cells and the impact on viral infection, the 
molecular mechanism of how parvovirus causes NEBD remains open. We hypothesize, for 
instance that PV may have a direct affinity or an indirect influence to caspase-3 activity through 
the modulation of the PDK/PKC pathway (figure A (3, 5)). The local enrichment may promote 
self-digestion of caspase-3 known to activate it (figure A (3)). However, our preliminary 
experiments could not give any evidence for a direct interaction favouring other models. 
Alternatively, PV may activate caspase-8 by promoting procaspase-8 dimerization that leads to 
activation (figure A (2)). Activated capsase-8 then could activate caspase-3 that cleaves different 
proteins of the NPC (nup153, RanBP2, nup214 and Tpr (Fahrenkrog.B, 2006, Ferrando-May.E, et 
al, 2001) and a PKC δ that becomes thereby activated; process that was described to occur during 
apoptosis (figure A (2, 3, 4). Active PKC δ activates cdk-2, and phosphorylates the lamin skeleton, 
leading to lamin depolymerization (figure A (5, 6, 8)). Indeed, PKC δ was shown to become 
activated upon MVM infection (Nüesch.P, unpublished).  
 
Nonetheless, other pathways appear possible we can not exclude that parvoviruses directly activate 
cdk-2 with the consequences described before (figure A (7, 8). In this scenario, cleavage of nup153 
by caspase-3 would not be involved. Another possibility is that H-1 recruits the PKC to the nuclear 
membrane to phosphorylate lamin B receptor and thereby permeabilize the lamina to facilitate the 
access of nuclear capsids to the inner nuclear membrane (figure A (5, 8)). 
 
Despite of the yet not understood pathway that is caused by the lack of knowledge on physiological 
NEBD, the presented data may help to design the future experiments on NEBD without the 
interference of cytosolic signal cascades. 
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Figure A: Hypothetical possibilities how parvoviruses may induce local NEBD. (1)
Parvoviruses (PV) interact with  different nucleoporins (blue). (3) PV may cause either local enrichment of 
activated caspase-3 (violet) or may activate caspase-3 directly by an unknown mechanism. This activated 
or accumulated caspase may lead to cleavage (black arrows) of some nups (blue) (4) and /or cleave PKC 
embedded into the inner nuclear membrane (INM);  which would result in an active PKC fragment (PKM) 
(sky blue) (5), PKM then leads to the activation of cdk-2 (orange) or according to the literature – may 
activate caspase-3 (Rosado.JA, et al, 2006) (6), Irrespectively PKM could then further phosphorylate the 
lamin structure (green) leading to lamin depolymerization (8). (2) Another possibility is that procaspase 8 
promotes the caspase-8 (brown) activation and this activates caspase-3 (violet). (7) Following another 
scenario, LAP2 (pink) become phosphorylated by PV activated cdk-2 (orange) which disconnects the 
contact of NPC (black) and chromatin (red) (8). (5) Furthermore PKC (sky blue) may phosphorylate the 
LBR (maroon) which is present on INM  resutling in lamin disassembly (green) (8). 
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7. Summary 
 
The parvoviruses are among the smallest DNA viruses, which infects the vertebrates and insects. 
They are divided into dependoviruses and autonomous parvoviruses. The dependoviruses depend 
on helper adenovirus or herpes virus to provide functions needed for their replication, whereas the 
autonomous parvoviruses, Parvovirus and Erythrovirus, do not need any helper virus for their 
DNA multiplication. 
 
Parvoviruses (PV) are non-enveloped, single stranded DNA viruses consisting of the structural 
proteins VP1 and VP2 and non-structural protein NS1. VP1 is the largest protein (83 kDa) contains 
NLS and a PLA2 activity that is not exposed on viral capsids. NS1 protein acts as a transactivator, 
which is covalently bound to viral DNA, and which is exposed on capsids surface. It is believed to 
be cleaved from the capsid upon uptake into the cells. Parvoviruses enter via clathrin-mediated 
endocytosis and need a low pH for productive infection. Parvoviruses exhibit 18-24 nm diameter, 
which is small enough to pass the NPC without any disassembled form.  
 
Accordingly some authors propose that NLS on VP1 that becomes exposed upon endosomal 
acidification mediates entry of the capsid into the nucleus. However microinjections, by passing 
the endosomes, generate progeny capsids being contradictory to this model. Other proposed that 
the PLA2 actively allows the capsids to pass the nuclear membrane, while others suggest that this 
activity is required for endosomal release. 
 
As the before mentioned models were based on the analysis of the autonomous parvoviruses MVM 
and CPV, we first evaluated whether our analysis done on parvovirus H-1 showed similar 
phenomenon. In fact we showed that acidification resulted in a structural change of the H-1 capsid 
resulting in the exposure of a NLS without leading to capsid disintegration. However nuclear entry 
did not occur upon infection but was shown to be caused by nuclear accumulation of progeny 
capsid or capsid subunits. 
 
Analysing the early steps of infection we found that H-1 caused a local nuclear envelope 
breakdown (NEBD). This phenomenon was reproduced in digitonin-permeabilized cells even in 
the absence of cytosolic proteins. Corrseponding experiments with CPV confirmed that this 
phenomenon was not H-1 specific. Further investigation showed that parvovirus-mediated NEBD 
was an enzymatically driven process involving PKC, cdk-2 and caspase-3 that are the executing 
enzymes in physiological NEBD upon mitosis and apoptosis. 
 
Inhibition experiments revealed that H-1 triggered NEBD by an interaction with the nulcear pores 
not requiring nuclear transport receptor that facilitate attachment. Infection experiments in the 
presence of PKC, cdk2 and caspase-3 inhibitors confirmed that all these enzymes were needed for 
PV-mediated NEBD upon infection. Further their inhibition blocked the appearance of progeny 
nuclear capsids. Further investigations revealed that PKC was however required for nuclear 
translocation of the progeny capsid subunits, cdk-2 for their synthesis while only caspase-3 did not 
affect these two steps. 
 
Indirectly these finding thus indicate that NEBD is essential for the entry of the parvoviral capsids 
upon infection, which is a new import principle for viruses. 
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8. Zusammenfassung 
 
Parvoviren (PV) gehören zu den kleinsten Viren überhaupt. Sie infizieren Vertebraten und Insekten 
und werden in Dependoviren und autonome PV unterteilt. Dependoviren benötigen die Hilfe von 
Herpes oder Adenoviren für Infektion oder Virusneusynthese, wohingegen die autonomen PV 
keinerlei Hilfe benötigen. 
 
PV sind nicht-umhüllte einzelstränge DNA Viren, die aus den Strukturproteinen VP1 und VP2, 
sowie aus dem Nichtstrukturprotein NS1 bestehen. VP1 ist da größte der Proteine und enthält ein 
Kerntransportsignal (NLS), sowie eine Phosholipase A2 (PLA2) Aktivität. Beide Aktivitäten, die 
auf dem N-Terminus des VP1 Proteins kodiert sind, sind jedoch nicht auf der Oberfläche der 
Virionen exponiert. NS1 ist ein Transaktivator, der kovalent an die Virus DNA gebunden auf der 
Oberfläche der Viren exponiert ist. Es wird angenommen, dass dieses Protein während des Eintritts 
in die Zelle abgespalten wird. 
 
PV werden über Endozytose in die Zelle aufgenommen und bedürfen eines niedrigen pH für eine 
produktive Infektion. Sie weisen einen Durchmesser von 18 – 24 nm auf, welcher klein genug ist, 
um einen Transport als intakte Partikel durch die Kernporen zu erlauben. 
 
Damit übereinstimmend postulieren einige Autoren, dass das NLS, welches im Zuge der 
endosomalen Ansäuerung exponiert wird, den Transport des intakten Capsides in den Zellkern 
vermittelt. Dementgegengesetzt belegten jedoch Mikroinjektionsversuche – bei denen die 
Ansäuerung umgangen wird – ebenfalls die Synthese von Nachkommenviren. Andere Autoren 
postulierten, dass die PLA2 Aktivität die Passage der Capside durch die Kernmembran vermitteln, 
wohingegen wieder andere Publikationen die PLA2 Aktivität dem Freisetzen der Capside aus den 
Endosomen zuordnen. 
 
Da die aufgezeigten Modelle auf der Analyse der autonomen PV MVM und CPV basieren, wurde 
in dieser Arbeit zunächst untersucht, ob die Analysen, die mit dem PV H-1 durchgeführt wurden, 
übertragbar sind. Tatsächlich konnte eine pH-bedingte Strukturänderung der Viruscapside 
beobachtet werden, die eine Exposition des NLS hervorrief, ohne jedoch die Capsidstruktur zu 
zerstören. Dessen ungeachtet konnte jedoch keinerlei nukleärer Import der infizierenden Capside in 
den Zellkern beobachtet werden. Einzig die Synthese von neuen Capsiduntereinheiten führte zu 
einer Akkumulation dieser, oder von kompletten Capsiden im Zellkern. 
 
Während der Analyse des frühen Infektionsvorganges konnte beobachtet werden, dass die 
Kernmembran lokal an den Stellen desintegriert wurde, an denen PV auf der cytosolischen Seite 
akkumulierten. Dieses Phänomen konnte ebenfalls in Abwesenheit cytosolischer Proteine in 
Digitonin-permeabilisierten Zellen beobachtet werden. Korrespondierende Experimente mit dem 
PV CPV bestätigte, dass dieses Phänomen nicht H-1-spezifisch war. Weitere Analysen zeigten, 
dass die PV-vermittelte Kernmembranzerstörung (nuclear envelope break-down, NEBD) ein 
enzymatisch katalysierter Prozess war, der PKC, Cdk 2 Kinase und Caspase 3, also die 
ausführenden Enzyme dieses Vorganges während Apoptose und Mitose, benötigte. 
 
Inhibitionsexperimente demonstrierten, dass der NEBD durch einen Kontakt zwischen H-1 und 
den Kernporen vermittelt wurde. Inhibitionen der PKC, Cdk 2 und Caspase 3 während Infektionen 
zeigten weiterhin, dass alle diese Enzyme auch dort den NEBD vermittelten und die Entstehung 
von nukleären neusynthetisierten Capsiden verhinderten. Nähere Charakterisierungen belegten 
jedoch, dass PKC den nukleären Import der Capsiduntereinheiten in den Zellkern verhinderten, 
Cdk-2 die Neusynthese blockierte, aber Caspase-3 weder mit Synthese oder Transport der 
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neusynthetisierten Intermediate interferierte. Indirekt implizieren diese Resultate also, dass der 
NEBD für das Eindringen der Capside in den Zellkern während der Infektion notwendig sind, 
welches ein völlig neues Prinzip für den Kerntransport von Viren darstellt. 
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